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ABSTRACT
This thesis adresses immunoglobulin heavy chain switch regions and variable 
regions in two hematologic B-cell tumors, mucosa-associated lymphoid tissue 
(MALT) lymphoma and B-cell chronic lymphocytic leukemia (B-CLL).
A high proportion of IgM+ MALT lymphoma cases were found to bear genetic 
alterations in the switch regions. Most of these switch region genetic alterations have 
been characterized through molecular cloning as chromosomal insertions and internal 
deletions but no new gene has been identified. Variable regions analysis revealed the 
presence of somatic hypermutations in all cases and intraclonal variation in a 
proportion of these. Correlation of somatic hypermutations and intraclonal variation 
with switch region alterations raised the possibility of two distinct subsets of MALT 
lymphoma with different maturation: one subset with aberrant isotype switch and no 
intraclonal diversification, and the other one with no aberrant isotype switch but with 
intraclonal diversification. Replacement versus silent mutation ratio analysis of 
complementarity-determining regions and frameworks indicated the positive 
selective pressure of an antigen in most cases. In two cases, protein translated from 
the third complementarity-determining region suggested the selective pressure of an 
autoantigen. A correlation of switch region alterations with clinical behaviour 
revealed that cases with rearrangements have a longer disease-free time after 
gastrectomy.
In B-CLL switch region analysis demonstrated the presence of switch region 
alterations in a proportion of cases (34%). These alterations are in most cases internal
deletions of the switch mu region and their role remains to be determined although 
their localization in the VhDJh rearranged alleles suggests a role in the stabilization 
of the isotype of the expressed immunoglobulin. Variable regions analysis showed 
somatic hypermutations in a proportion of cases and no correlation with switch 
region deletions was detected. No significant correlation between switch region 
deletions and prognosis was observed, indicating that internal deletions have no 
consequence for disease outcome. Moreover no significant correlation between the 
presence of switch deletions and somatic hypermutations was found, indicating that 
the two processes giving rise to internal deletions and somatic hypermutations, are 
independent in B-CLL.
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Chapter 1
INTRODUCTION
1.1 Blood cell biology
Blood cells grow, divide and differentiate in the bone marrow (BM) through a 
process called hematopoiesis. Three general classes of cells are produced: red blood 
cells, responsible for oxygen transport, platelets, responsible for the control of 
bleeding and white blood cells mostly involved in host defence (Figure 1). All three 
classes are derived from a pool of pluripotent hematopoietic stem cells (HSC) which 
reside in the BM and are self-renewing cells; when they proliferate some of the 
daughter cells remain as HSC so that the pool never becomes depleted. In most cases 
when these cells differentiate their capacity for replication and self-renewal declines 
and they are called “terminally differentiated”. The mature cells of the myeloid 
lineage include neutrophils, monocytes, mastcells, eosinophils, basophils and 
megakaryocytes which produce platelets. Mature cells of the lymphoid lineage 
include B and T lymphocytes and natural killer (NK) cells. The bone marrow 
hematopoiesis is controlled at several levels in order to maintain an available pool of 
HSC, regulate the commitment, proliferation and differentiation of cells and 
modulate the activity of each pathway in response to physiologic demands. Much of 
this regulation is achieved through physical interactions of the hematopietic cells 
with other cells and with soluble factors in the surrounding tissue. By activating 
specific signal transduction pathways inside the developing cells the external stimuli 
modulate the activity of transcription factors, cell cycle regulatory factors, and other
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intracellular proteins that determine whether a cell will proliferate, differentiate or 
die (Ogawa, 1993; Uchida et ah, 1993; Kincade et ah, 1989).
Human HSCs are CD34’^ CD38‘, are small with round nuclei and scant cytoplasm and 
comprise no more than 0.01% of all cells in the BM. Most are mitotically inactive 
and when cultured in vitro can be induced to proliferate by treating with cytokines 
like interleukin 3, interleukin 5, granulocyte colony stimulating factor, macrophage 
colony stimulating factor, granulocyte-macrophage colony stimulating factor etc. 
When progenitor cells are deprived of an essential cytokine they cease growing and 
often die though apoptosis.
1.2 Lymphocytes and lymphoid tissues
The typical lymphocyte is a small, round cell, 5-12|Lim diameter, with a spherical 
nucleus, densely compacted chromatin and scant cytoplasm. The cytoplasm contains 
scattered mitochondria and free ribosomes but lacks any distinctive organelles. 
Several types of lymphocytes can be distinguished by functional properties and 
proteins expression. The most fundamental distinction is the division into T, B and 
NK cells. The proportions of T and B cells vary among tissues; in peripheral blood T 
cells account for 75% and B cells for 10% of all lymphocytes. The remaining 15%  
are NK cells.
T and B cells derive from the BM HSC following different pathways of maturation. 
B cells mature uniquely in the BM while T cells undergo part of the process in the 
thymus. Thymus and BM are the primary lymphoid organs. Secondary lymphoid 
organs serve for the encounter between lymphocytes and foreign antigens (Ags). If
14
lymphocytes do not encounter any foreign Ag they die within few days; otherwise 
activation occurs and permits life for several years (Butcher and Picker, 1996).
1.2.1 B cells
B cells defining feature is their ability to synthesize immunoglobulins (Igs) which are 
called antibodies (Abs) and are able to bind the antigens (Ags). In resting B cells Igs 
are expressed only on the surface, where they serve as receptors for specific antigens. 
When an activated B cell divides, some of its progeny become memory B cells and 
the remainder differentiate into plasma cells (PC) which secrete large amounts of Igs 
into the surrounding media. PC have oval shape and abundant cytoplasm. The 
protein-secretory organelles are well represented, including a large Golgi apparatus 
and abundant endoplasmic reticulum. Lifespan is short, usually days or a few weeks. 
B cells main function is production of Igs which constitute the humoral immunity but 
they function also as antigen presenting cells (APCs) and secrete certain 
lymphokines (Rolink and Melchers, 1991; Sprent and Tough, 1994).
1.2.2 T cells
T cells do not express Igs but instead detect the presence of foreign substances by 
way of surface proteins called T-cell receptors (TCRs). TCRs are closely related to 
Igs in evolution but they are never secreted and require direct contact with a target to 
have activity. Together with macrophages T cells are involved in cell-mediated 
immunity. T cells will recognize proteins only if cleaved into small peptides 
displayed on APCs. Specialized APCs are mainly macrophages and B lymphocytes
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and presentation occurs through specific proteins forming the major 
histocompatibility complex (MHC) on the cell surface. Binding of foreign substances 
to MHC is non-covalent and TCRs must encounter the complex to produce 
immunologic effects. TCRs are made up of two chains (usually a  and P) and are 
always expressed in association with other transmembrane peptides forming the CD3 
complex. This complex transmits signals onto the cytoplasm and is essential for TCR 
surface expression. CD3 is expressed late in T cell ontogeny. CD2 appears instead at 
an earlier stage and is useful as a marker for T cell lineage. Different T cell 
populations exist each with their specific role. CD8^ T cells constitute about 25% of 
all PB T cells and have cytotoxic activity against cells carrying foreign molecules on 
their surfaces (i.e. cells infected by viruses). CD4^ T cells are about 70% of all T 
cells and function as T helper (Th) cells which promote proliferation, maturation and 
immunologic function of other cell types. A small proportion of T cells (4%) residing 
outside the thymus are double negative (CD4‘ and CD8’) and express a different form 
of TCR with yô chains. Double positive cells (CD4^ and CD8 )^ constitute only 1% of 
the T cell population. When activated, T cells can undergo several divisions to 
produce daughter cells which become effector cells with helper and cytotoxic 
activity. Effector cells have more cytoplasm and looser chromatin in addition to 
specific surface proteins such as CD25, CD28, CD29 CD40L and MHCII. When the 
stimulus is withdrawn, the effector activity declines over a period of several days and 
the T cells either die or revert to the resting state (Sprent and Tough, 1994).
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1.2.3 Lymphocyte activation
Lymphocyte activation occurs through the binding of specific ligands to receptors on 
the lymphocyte surface and determines proliferation and expression of immunologic 
functions. Ligands for T and B cells are different but the activation process is very 
similar. The earliest event is an increase in protein tyrosine kinases (PTKs) within a 
few seconds of activation. One immediate effect of the PTK cascade is the activation 
of the phospholipase C-yl which then hydrolyzes specific phospholipids in the 
cellular membranes producing diacylglycerol (DAG) and inositoltriphosphate (IP3). 
These are second messangers; DAG activates protein kinase 3 and IP3 determines a 
rapid increase in Ca++ ions. Within the first hour after stimulation the DNA, RNA 
and protein synthesis rise significantly. In parallel the morphology of the cell 
changes in a process called blast transformation (Weiss and Littman, 1994; Gold and 
DeFranco, 1994).
1.2.4 Thymus and bone marrow
The thymus is involved in T lymphocyte production and maturation and it is 
composed of two lobes, each comprising multiple lobules. Lymphocytes are packed 
densely toward the periphery which assumes the appearance of an outer cortex. Apart 
from epithelial cells, a few macrophages and other supporting elements, all cells in 
the thymus are T lymphocytes, also called thymocytes. Of these 10% are CD4- CD8- 
, have a high mitotic rate and are thought to be T cell precursors. 15% are CD4+ or 
CD8+ and are preparing to leave the organ. The remaining population is CD4+ 
CD8+ and represents an intermediate stage of T cell development. Most of them die 
because of a rigorous selection essential to create a functional immune system but
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those which survive become single positive and then leave to the secondary 
lymphoid organs.
The bone marrow can be thought of as a solid tissue in which different types of 
HSCs develop in physically different locations. These microenvironments are visible 
in histologic sections of BM which reveal microscopic foci, each devoted to the 
production of a particular cell type. All is set up and mantained by BM stromal cells. 
BM cells are able to interact with one another or with proteins and other substances 
that make up the extracellular matrix (ECM). Hematopoiesis depends not only on 
specific cytokines but also on a group of cell surface macromolecules known as 
adhesion molecules (integrins, selectins and various forms of CD44).
1.2.5 Lymph nodes, spleen, tonsils, Peyer’s patches.
Lymph nodes are bean-shaped organs distributed along the entire lymphatic 
vasculature, especially in the neck, axillae, inguinal regions and root of the 
mesentery. They contain aggregates of lymphocytes and macrophages and 
connective fibers called reticulin and function as a physical filter where immune cells 
survey for microrganisms and macromolecules that may be present. The node is 
surrounded by a fibrous capsule. Lymph flows into the node along afferent lymphatic 
vessels and enters a subcapsular sinus, lined primarly by macrophages. Then it 
percolates sequentially through two regions called cortex and medulla and finally 
exits through an efferent lymphatic vessel on the opposite site. The cortex contains 
the lymphoid follicles composed mainly of memory B cells, a small number of T 
cells and follicular dendritic cells. Lymphoid follicles can disappear and reappear 
over time and can enlarge in response to immune challenges. They are of two types:
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primary follicles, containing mature resting B cells and secondary follicles or 
germinal centers, containing mature B cells in the mantle zone and developing B 
cells in the light zone (Szakal et ah, 1989; MacLennan, 1994). Proliferating B cells in 
the germinal center undergo class switch recombination and a process called 
affinity maturation.
The spleen is located below the diaphragm on the left side of the abdomen and filters 
blood as the lymph nodes filter lymph. Blood enters through the splenic artery and 
passes through a network of smaller arterioles encased in a cuff of lymphoid tissue 
consisting of mature T cells. Primary and secondary lymphoid follicles, composed 
mainly of B cells, protrude from the lymphoid tissue. All this constitutes the white 
pulp and permits the flow of blood to the red pulp which is formed by reticular cells 
and macrophage-lined vascular sinusoids. Eventually blood exits by way of the 
splenic vein. Flowing through the spleen, blood cells recognize infectious agents, in 
addition to recognizing abnormal or damaged red or white cells.
Tonsils are aggregates of macrophages and lymphoid tissue located beneath the 
epithelium of the nasopharynx and soft palate. They detect and respond to pathogens 
in the respiratory and alimentary sections.
Peyer’s patches are lymphoid nodules present in the ileal submucosa of the small 
bowel where they detect substances that diffuse across the intestinal epithelium.
1.2.6 The mucosal immune system
The mucosal immune system is composed of lymphoid tissues associated with 
mucosal surfaces of the gastrointestinal (GI), respiratory and urogenital tracts. It is 
characterized by the presence of a mucosa-related IgA, T cells with specific
19
properties and a homing system that allows lymphocytes to migrate to subepithelial- 
tissues. The primary function is to provide host defences at mucosal surfaces where it 
operates in concert with resident bacterial flora. It provides substances such as gastric 
acid and secretions that create an unfavorable environment and inhibitory subtances 
such as lysozyme that inhibit specific microorganisms. Another important function is 
to prevent the entry of foreign antigens into circulation avoiding an inappropriate 
immune response.
1.2.6.1 Mucosa-Associated Lymphoid Tissue (MALT)
All lymphoid tissue of submucosal regions is called Mucosa-Associated Lymphoid 
Tissue (MALT) which secretes antibodies as a defence against external pathogens. It 
appears that MALT has evolved to protect the mucosal tissue which is in contact 
with antigens in the external environment. MALT of the GI tract comprises four 
lymphoid compartments: the Peyer’s patches, the lamina propria, the intraepithélial T 
lymphocytes and the mesenteric lymph nodes. Briefly, the Peyer’s patches are 
composed mainly of B cells, are not capsulated and lack afferent lymphatics; their 
structure consists of a central follicle surrounded by a marginal zone with a dome 
epithelium. The lamina propria is composed of plasma cells, B and T lymphocytes, 
macrophages and APCs. Intraepithélial T lymphocytes consist mostly of CD8+ T 
cells and mesenteric lymph nodes form the interface between MALT and the 
peripheral immune system. Antigens enter the Peyer’s patches from the gut by a 
direct mechanism involving specialized “M” cells and stimulate MALT B cells that 
leave the mucosa and enter the circulation. These B cells then come back to the gut 
and constitute the lamina propria plamacells.
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1.2.6.2 IgA
The mucosal system is rich in IgA which has properties allowing it to function 
efficiently in the mucosal system. The main properties of IgA are: polymerization 
and interaction with secretory components, resistance to proteolysis, anti­
inflammatory and pro-inflammatory properties. IgA exists in two forms: IgAl 
mainly circulating and IgA2 abundant in secretions of the GI tract. Circulating IgAl 
is generally a monomer, whereas mucosal IgAl and IgA2 are generally dimers or 
multimers. The different properties between the two IgAs are confered by 15-20 aa 
in the constant domains. IgAl has a long proline-rich hinge region that confers 
flexibility to the antigen-binding site but also susceptibility to the proteinases 
secreted by numerous bacteria. In addition, it has more galactose residues which bind 
a receptor on hepatocytes. IgA2 displays more truncated oligosaccharides which bind 
certain organisms which might colonize the mucosal surfaces. Finally, IgA2 has two 
allotypic forms designated A2M2 and A2M1. In humans, most circulating IgA is 
produced in the BM in the form of IgAl monomers whereas secretory IgA is 
produced mainly at mucosal sites either as IgAl or IgA2 dimers or polymers.
Why do IgAs develop mainly in mucosal tissues? One factor is the presence of 
activated T cells that influence B cells to undergo IgA-specific isotype switching 
(McIntyre et al., 1995). These cells are able to produce TGFp which promotes IgA 
switching in addition to expression of CD40L and other not yet identified surface 
molecules necessary for IgA switch differentiation (Mestecky and McGhee, 1987).
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1.2.6.3 Other Igs in the mucosa
Igs other than IgA also play a critical role in the mucosal immune system. IgM can 
be transported across epithelial cells, is measurable and physiologically significant. It 
is an adequate replacement for IgA in individuals with selective IgA deficiency. IgG 
is quite low and can not be transported across the epithelium, but is an important 
antibody in pulmonary secretions. IgE is synthethized in mucosal tissue particularly 
during parasitic infection or in relation to allergic states.
1.3 Immunoglobulins and Immunoglobulin genes
Immunoglobulins (Igs) are a huge family of related glycoproteins with various 
functions. The two hallmarks of Igs as antigen-binding proteins are the specificity 
and the diversity. In addition, however, Igs also possess secondary biologic activities 
that are critical for host defence, including the ability to function as opsonins, to 
activate the complement cascade or to cross the placental barrier. Every Ig is made of 
two different types of polypeptide: the heavy chains and the light chains. These 
chains are held together by noncovalent forces and by disulfide bridges. The 
sequences of the chains show great variability in the N-terminal domain which is 
called the variable region (V region). The other domains are called constant domains 
(C domains). Five classes of constant heavy chain (y, a , p, ô, s) and two types of 
light chain (K and 1) are expressed by humans, with different subclasses and 
molecular weight. Igs of all classes can exist in either membrane-bound or secreted 
forms. The membrane forms contain at the C terminus 12-14 acidic amino acids 
followed by a hydrophobic sequence of 26 residues which anchors the heavy chain 
into the cell membrane. This direct anchoring occurs only in B cells. Secreted Igs
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lack the terminal transmembrane segment as a result of alternative RNA splicing. 
They contain instead terminal sequences called tail pieces that mediate 
polymerization of four chain units and also serve as contact sites for the J chain.
1.3.1 Biologic activity
The Ag binding activity is localized in the VH and VL domains and the other 
activities in the CH domains.
IgGs account for about 75% of the total serum Igs in adults and are the most 
abundant Abs produced during secondary humoral immune response. In particular, 
IgGl is the most concentrated followed by IgG2, IgG3 and IgG4. IgGs are the only 
ones to cross the placenta in humans and are responsible for protection of the 
newborn during the first months of life. IgG-Ag binding activates the serum 
complement. Finally, macrophages and other cell types express receptors that bind 
the Fc regions of IgG molecules (Spiegelberg, 1974).
IgA. IgA is the predominant Ig produced by B cells in Peyer’s patches, tonsils and 
other submucosal lymphoid tissues although it accounts for only 10-15% of serum 
Ig. On B cells surface IgA exists as monomer while the predominant secreted forms 
are dimers and trimers. The two subclasses, IgAl and IgA2, are expressed at a 5:1 
ratio in the blood and have similar properties.
IgM. IgM constitutes about 10% of serum Ig and is normally secreted as a pentamer 
with a mass of 900 kD. It predominates in the primary immune response and tends to 
dilute subsequently. It is the most common Ig on B cells and it is also the most 
efficient complement-fixing Ig.
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IgD. IgD is a monomeric four chain unit coexpressed with IgM on the membrane of 
naïve B cells. Both classes are expressed by alternative splicing of a single mRNA 
and have identical Ag specificity. It is rarely secreted in significant amounts and its 
physiologic function is unknown. Its presence on naïve B cells has suggested a role 
in differentiation or tolerance.
IgE. It is very important from the clinical standpoint because it is involved in allergic 
disorders, even though it is present at very low concentrations (0.004%). Indeed, 
inflammatory cells, such as mast cells and basophils, carry a high affinity Fc receptor 
specific for IgE antibodies. Thus, the surfaces of these cells are decorated with IgE 
that serve as Ag receptors. When IgEs contact an Ag, inflammatory cells release 
substances that produce many manifestations of allergic disease.
1.3.2 Human Ig loci
Genes encoding Igs are dispersed along genomic DNA and only developing 
lymphocytes possess the enzymatic machinery to undergo the process of Ig gene 
rearrangements.
Light chain genes. All genetic information to produce kappa chains lies on 
chromosome 2 (Figure 1.2-A). The constant domain is encoded by one exon (C k) 
present in single copy. The variable domain, however, is contained in two segments 
called Vk and Jk. Vk codes for the first 95aa and Jk for the remaining 13aa. Multiple 
Vk and Jk segments are present: about 35 Vk and 5 Jk. Through V/J joining the Vk 
and Jk segments become covalentely joined to one another to form a single exon. 
Transcription begins in one VK segment, passes through the fused exon and CK 
exon synthesizing a primary transcript which is then spliced to form mature kappa
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chain mRNA. Lamba chain genes arise from a similar gene complex on 
chromosome 22. The only difference is that there can be up to six different copies of 
the CL exon each with a nearby JL segment (Figure 1.2-B).
Heavy chain genes. All heavy chains derive from a region spanning about 700.000 
bp on chromosome 14 (Figure 1.3). Each heavy chain is encoded by several exons. 
For example, the \x constant region is encoded by five exons known as the Cp 
sequence; the same happens for the other isotypes. In contrast to the light chain 
genes, a third type of segment, called the diversity segment (DH), is used in forming 
a variable heavy chain. This segment codes for two or three aa and lies between the 
VH and JH segments on the unrearranged chromosome. A B cell must complete a 
V(D)J joining in order to express a heavy chain. Use of the DH segment and errors of 
a few nucleotides inserted by the enzyme terminal deoxyribonucleotide transferase 
(TdT) at the joining sites greatly increase the VH chain diversity. TdT is an enzyme 
that inserts a few nucleotides of random sequence, called N regions, at the points of 
joining between the V, D and J segments (Komori et al., 1993). Only the CH region 
downstream of the V(D)J rearranged exon can be expressed and therefore the gene 
always produces p chains when it is first rearranged. Expression of other isotypes 
occurs only after a subsequent recombination called isotype switch recombination. 
This recombination occurs at specific sites called switch regions which lie in front of 
C genes (see 1.4.2. for further details). One exception is the Cô gene which is 
transcribed with Cp. This produces an RNA that can be spliced to yield either p or ô 
mRNA enabling the cell to express IgM and IgD at the same time. Such coexpression 
is a feature of naive B lymphocytes.
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1.4 B cell development
Lymphocyte development is among the most intensively studied examples of 
progressive lineage commitment and serves as a prototype of mammalian cell 
differentiation. Several genes regulate stem cell commitment to lymphoid 
differentiation. PU-1, a transcription factor of the Ets family, Ikaros, a DNA-binding 
protein, EBF, a regulator of mb-1 which encodes for Iga, E2A transcription factors. 
The B cell develops and matures in the BM while differentiates in the peripheral 
lymphoid organs (Figure 1.4). B cell development in the BM can be defined by 
expression of a variety of cell surface markers and by the status of Ig gene 
rearrangements. CD43^ pro B cells undergo a first Ig rearrangement becoming early 
pre B cells. These further differentiate into smaller CD43" late pre B cells in which 
rearrangement of the light chain loci occurs and results in production of surface- 
expressed Ig. This signal triggers differentiation into naive (virgin) B cells which 
express IgM and IgD. B cells with self-reactive Igs are deleted by induction of 
programmed cell death within the BM. The remaining cells migrate out of the BM to 
replenish the peripheral immune system. In the periphery, unstimulated B cells die 
within a few days while stimulated B cells get activated and differentiate through T 
cell help in the germinal centers of the spleen and lymph nodes. Within germinal 
centers, B cells undergo important changes including isotype switch (1.4.2), affinity 
maturation (1.4.3), plasma cell differentiation and the generation of memory cells 
(1.4.4) (Arpin et al., 1995; Li et al., 1993).
Germinal centers (GC) are complex structures that form in the spleen and lymph 
nodes in response to antigenic challenge. In addition to B cells they contain antigen- 
presenting cells (APCs) and T helper (Th) cells. There are three histologically
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distinct microenvironments within the GC. The mantle zone contains small resting B 
cells that have not yet been antigenically selected. Activation of these B cells induces 
proliferation and somatic hypermutation which occur in the dark zone. Surviving 
clones enter the light zone where proliferation slows and affinity selection 
predominates. GC development remains poorly understood but a number of factors 
involved have been recently identified. CD 19 is a potent costimulator of Ig-mediated 
signaling and is expressed throughout B-cell development. Bcl-6 is a transcriptional 
repressor highly expressed by activated B cells. Bcl-3 appears to enhance nuclear 
factor kB (Nf-kB) DNA binding. Tumor necrosis factor a  and p (TNFa and TNFP) 
regulate humoral and cellular immune responses and their gene inactivation results in 
disruption of GCs. Finally, BSAP is an important regulator of early B cell 
development but also of late stages, during activation and isotype switching. Isotype 
switching, which also occurs in GCs, allows the production of IgG, IgA, IgE in 
response to specific cytokines (MacLennan, 1994).
Activated B cells ultimately choose between death or differentiation into plasma 
cells (PCs) or long-lived memory cells which constitute the basis for the response to 
antigenic rechallenge in a secondary immune response. Memory B cells migrate to 
the bloodstream and PCs to the BM, becoming mature PC.
1.4.1 The mechanism of V(D)J recombination
V(D)J recombination fuses a large selection of gene segments to form functional 
heavy and light chains generating, through different combinations, great antibody 
diversity (Oettinger, 1996; Alt et al., 1987; Lewis, 1994). Recombination signal
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sequences (RSS) are non-coding motifs which flank V and J segments necessary for 
V(D)J recombination (Akira et ah, 1987; Hesse et ah, 1989). They consist of 
conserved heptamer and nonamer motifs separated by 12 or 23bp spacers. (Figure 
1.5A). V(D)J recombination in vivo occurs only between motifs with different length 
spacers (12 or 23) (Tonegawa, 1983). Two proteins, RAGl and RAG2, are essential 
for V(D)J recombination. Their genes are extremely close in the genome and have 
the unusual feature of lacking introns (Schatz et ah, 1989; Oettinger et ah, 1990). 
RAGl and RAG2 are able to carry out in vitro the initial steps of V(D)J 
recombination. These steps occur upon single strand nicking and nucleophilic attack 
by the resulting 3’ hydroxyl on an adjacent phospodiester bond of the opposite strand 
which causes a double strand break with a hairpin loop on the coding end. These 
hairpins are intermediates in the process of V(D)J recombination in vivo. One other 
important enzyme involved in V(D)J recombination is a DNA dependent protein 
kinase (PK) specific for serine and threonine residues, which has the role of 
repairing double strand DNA breaks (Kirchgessner et ah, 1995; Blunt et ah, 1995; 
Peterson et ah, 1995). Mice deficient for RAGl and RAG2 (Mombaerts et ah, 1992; 
Shinkai et ah, 1992) or with mutations in DNA-PK (SCID mice) (Bosma et ah, 1988) 
show defects in different stages of B-cell develoment.
When RSS are joined together the DNA that originally separated V and J segments 
can be released as a covalently closed circle (which is then degraded) or it can be 
removed by way of an inversion (Figure 1.5B).
Rearrangements occur first on the IgH locus, between D and JH gene segments, and 
later between VH and DJH. Only after the formation of functional rearrangement of 
the IgH locus, the IgL locus rearranges, kappa genes preceding lamba genes. The 
formed receptor associates with two other transmembrane molecules, Ig alfa and Ig
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beta. This dimer is required for cell surface expression and signalling which appears 
to act through activation of the tyrosine kinase Syk. This complex represses RAGl 
and RAG2 genes although the intracellular components of these signalling pathways 
have not yet been described. This ordered rearrangement of the Ig genes appears to 
derive from controlled sequential accessibility to the recombinase machinery. The 
precise mechanisms governing the accessibility of antigen receptor loci are not fully 
understood, although the so called sterile transcripts may open the locus by causing 
displacement of inhibitory or masking proteins (Willerford et al., 1996; Sleckman et 
al., 1996).
1.4.2 Isotype switching
Isotype switching or class switch recombination (GSR) occurs in activated B cells 
and permits the exchange of the constant region of the heavy chain from IgM/IgD to 
IgG, IgA, or IgE. This rearragement occurs by deletional recombination between 
switch regions located upstream of each constant gene segment and serves to alter 
the effector function of the antibody molecule. No consensus or homologous 
sequence is found around switch regions and GSR can be classified as region- 
specific recombination.
The order of the constant region genes in the IgH locus, starting from the telomeric 
end, is p, 5, y3, yl, v}/s, a l ,  v|/y, y2, y4, and a2. Isotype switch from p to y, a , or s is a 
developmentally regulated DNA recombination event that occurs between Sp and the 
respective isotype switch region, resulting in the formation of a hybrid switch region. 
The switch regions are 1-3 kb long, consist of tandem pentameric repeats, and are 
located just upstream of p, y3, yl a l ,  y2, y4, and a2 constant segments. There is no
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conventional switch region upstream of ô, v|/s or \|/y. However, isotype 
recombination to ô can occur by homologous recombination between duplicated 442- 
bp sequences that are located upstream of Sp and the first exon, respectively 
(Bergsagel et al., 1996).
A "physiological” IgH switch recombination occurs between two IgH switch 
regions, resulting in the formation of a hybrid switch region. This may be a 
productive switch from p to another isotype, a downstream switch not involving p, or 
an inversion event between switch regions (Figure 1.6). In most cases, these 
recombination events occur on the same chromosome (cis), but occasionally occur in 
trans (recombination between sister chromatids or homologous chromosomes). An 
’’aberrant" IgH switch recombination, which is defined as involving only one IgH 
switch region, may be a chromosomal translocation, an interstitial deletion, an 
interstitial insertion, or an inversion into a switch region. A shematic representation 
of the possible switch recombinations is shown in Figure 1.6. When the Sp region is 
joined to a downstream switch region the intervening DNA is loopped out and 
excised as switch circular DNA (switch circle) resulting in the expression of the 
downstream isotype.
The entire process generating switch circles can be divided into 3 steps: choice of a 
downstream switch region, recognition and cleavage of the target DNA by the 
recombinase and repair and ligation resulting in switch circles.
1.4.2.1 Selection of the target
Stimulation by a specific cytokine determines the target switch (S) region and thus, 
the immunoglobulin class generated by CSR. In mature B cells, the Sp region is
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constitutively transcribed from the intronic promoter (I) located 5' to the Sp region, 
whereas transcription of downstream S regions is induced only after stimulation with 
specific cytokines (i.e interleukin 4). Each cytokine activates specific intronic 
promoters that are located 5' to S regions, giving rise to the so-called germline 
transcripts that contain the intronic promoter and the constant exons. Germline 
transcripts are required for effective CSR and recently it was demonstrated that there 
is a direct correlation between the amount of germline transcripts and class switch 
efficiency (Lee et al., 2001).
Splicing removes the S region sequence from primary transcripts. A close association 
between isotype specificity of germline transcription and the recombination target of 
S regions by stimulation with a given cytokine has led to the accessibility model, 
whereby germline transcription opens the chromatin structure of a specific S region 
and renders it accessible to a putative recombinase (Yancopoulos et al., 1986). 
Several gene-targeting experiments abolishing germline transcription (Gu et al., 
1993; Jung et al., 1993; Zhang et al., 1993; Seidl et al., 1998) confirmed that this 
process is required during CSR. Transcription-dependent locus opening had been 
also shown to be required for V(D)J recombination (Blackwell et al., 1986).
1.4.2.2 Récognition of target DNA
To understand the cis elements that are required for CSR, various in vitro assay 
systems were developed using artificial DNA constructs and B cells or B cell lines 
(Ott et al., 1987; Leung and Maizels, 1992; Lepse et al., 1994; Daniels and Lieber, 
1995; Christine et al., 1999; Stavnezer et al., 1999; Kinoshita et al., 1998). One of the 
most effective was a system using an efficiently switching mouse lymphoma cell line
31
(CH12F3-2), in which 80% of the cells switch from expressing IgM to (almost 
exclusively) IgA in one week after stimulation with CD40L and IL-4. Constructs 
containing Sp and Sa regions in front of surface expression markers were introduced 
into CH12F3-2 cells. CSR requires cytokine stimulation, indicating that the 
stimulation induces activation of new genes involved in CSR such as activation- 
induced cytidine deaminase (AID) (see 1.4.4 for details on this enzyme) (Kinoshita 
et al., 1998; Muramatsu et al., 2000). Studies using several other types of artificial 
construct in combinations of B cell lines and spleen cells (Leung and Maizels, 1992; 
Lepse et al., 1994; Daniels and Lieber, 1995; Ott and Marcu, 1989) have clearly 
shown that the S region is essential for CSR. Furthermore, knockout mice with 
disruption of the core S region showed decreased levels of class switching to all 
isotypes (Luby et al., 2001). Residual switching observed in these mice might be due 
to the presence of scattered S repeat motifs outside the core S region.
The class-switch recombinase might recognize the secondary structure of S regions 
rather than the primary sequence. Evidence for this idea includes the fact that the S 
regions of different isotypes and species (chicken and frog), as well as an inverted S 
region, are functional in CH12F3-2 cells, which switch almost exclusively to IgA. 
Scrutiny of recombination junctions in mammalian and amphibian CSR — in both 
endogenous loci (Mussmann et al., 1997) and artificial substrates (Tashiro et al., 
2001) — revealed that their distribution is biased to the proximity of the stem-loop 
structure in single-stranded S sequences, which is predicted by a computer program 
based on thermodynamic parameters (SantaLucia, 1998). Because S sequences, 
irrespective of the isotypes and species, commonly contain many short stretches of 
inverted repeats, the stem-loop structure may be formed when they are single 
stranded.
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1.4.2.3 Cleavage and repair.
Using artificial substrates that direct CSR it was demonstrated that deletions and 
duplications of variable lengths occur at junction sites (X.C. Chen, K.K. and T.H., 
unpublished data). The introduction of duplications during CSR indicates that DNA 
breaks in S regions are due mainly to staggered nicks (double strand break that 
produces protruding ends) on two strands of DNA. Because cleaved ends are joined 
by the non-homologous end joining repair (NHEJ) systems during CSR, single­
stranded tails of staggered ends might be blunt-ended by exonueleases and might 
involve error-prone DNA polymerases. During these processes, frequent mutations 
are introduced in the region surrounding the recombination breakpoints.
In the course of recent studies on Hairy Cell Leukemia it has been proposed that CSR 
might occur not only with deletions at the DNA level but also through RNA splicing. 
Indeed HCL cells express simultaneously transcripts of multiple isotypes. This could 
not be possible considering only the “switch deletional mechanism” because in this 
model the isotypes located between the p and the target isotype would be deleted. An 
RNA splicing event, preceding CSR, would allow the expression of multiple isotypes 
at the RNA level (Forconi et al., 2001).
Like V(D)J recombination isotype switching is regulated at multiple levels. As 
discussed above, the enzymatic machinery operates through generation of double­
strand breaks and rejoining of the looped-out DNA. Accessibility of switch regions 
requires germline transcription of the IgH constant genes which is regulated by 
multiple factors including surface Ig crosslinking, CD40 receptor engagement and 
soluble cytokines such as IL4, IFN y, and TGF p.
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Four enhancers, located 3’ to the IgH locus, strongly affect the efficiency of CSR. It 
has been demonstrated that Ca3/hs3a and hsl,2 are dispensable for switch 
recombination and that hs3b and hs4 impair CSR if deleted (Finaud et al., 2001).
CSR capacity has been tested for various CD27 memory B cells. IgM+IgD- and 
switched-memory cells have low switch capacity compared with IgM+D+ cells 
which undergo readily sequential switch recombination when properly stimulated. 
IgM only cells might undergo abortive switch and switched cells might bear 
alterations which impair switching capacity (Werner-Favre et al., 2001).
Several important proteins involved in CSR have been characterized recently and the 
most intriguing aspect is the finding that many of them also have a fundamental role 
in the process of somatic hypermutation (SHM). The most important are
1) CD40-CD40L intraction with Nf-kB activation
2) NEMO (Nf-kB essential modulator)
3) Activation-induced cytidine deaminase (1.4.3.3)
4) Mismatch-repair proteins
1.4.3 Somatic hypermutation
Somatic hypermutation (SHM), occurring within the follicular GC dark zone, 
increases the mutation rate of the heavy and light variable regions. This process 
increases diversity within the antigen-binding pocket of the Ig receptor. Affinity 
maturation derives from the combination of SHM and stringent antigen-driven 
selection and results in antibodies with much greater affinity and specifity for target 
antigens in a secondary immune response. Although it is unknown which strand is 
targeted for mutation, the mutational process has a strand bias, favouring purine
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substitution on the coding strand. The mechanism is not fully understood but it 
appears quite specific as adjacent regions are not affected. DNA repair proteins have 
been identified as components of the RNA polymerase II transcription initiation 
complex. SHM introduces point mutations specifically in immunoglobulin V genes 
of activated B cells at an extraordinarily high frequency (10‘^  bases per generation) 
(Storb et al., 1998; Jacobs and Bross, 2001). This frequency is roughly one million 
times higher than the level of mutation during normal DNA replication (10'^ bases 
per generation). Not all switched Igs undergo SHM, and conversely, some IgM have 
SHMs, indicating that neither CSR nor SHM is a prerequisite of the other. SHM 
occurs even in the absence of CD40-CD40L interaction in patients with hyper IgM 
syndrome (HIGM). For this reason it is hypothesized that an alternative 
diversification pathway must exist (Weller et al., 2001).
1.4.3.1 Selection and recognition of the target.
Transcription seems to be essential for SHM. Mutations are commonly found within 
a 1.5-2-kb region that lies 3' to the promoter region of the rearranged V gene, 
regardless of families and endogenous or transgenic loci, and mutations upstream of 
the transcription start site are extremely rare. Moreover, the intronic enhancer and 
promoter have been shown to be required for SHM (Betz et al., 1994). Because the 
mutation rate is positively correlated with the transcription efficiency (Fukita et al., 
1998; Bachl et al., 2001), it should be carefully examined to find out whether the 
enhancer sequence is essential for functions other than transcriptional activation, as 
proposed (Papavasiliou and Schatz, 2000). As in the case of CSR, SHM does not 
seem to have a clear primary-sequence specificity.
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Storb and colleagues (Storb et al., 1998) proposed that transcription is required to 
recruit a putative mutator (possibly a 'nickase'). According to their model, the 
mutator can bind to RNA polymerase II during initiation of transcription, and be 
transferred to DNA when the RNA polymerase pauses because of a secondary 
structure (stem-loop) of the nascent transcript. Kolchanov and colleagues 
(Kolchanov et al., 1987) speculated that the mutator might recognize non- 
complementary base pairs in the stem-loop structure of the V-region genes because 
the abundance of complementary palindromes in V-region genes is about four times 
higher than that in other genes including immunoglobulin C-region genes.
1.4.3.2 Cleavage
Most models describing SHM propose a break of DNA strand(s) but direct evidence 
to support DNA cleavage during this process has only recently been obtained 
(Papavasiliou and Schatz, 2000; Goossens et al., 1998; Wilson et al., 1998; Sale and 
Neuberger, 1998; Bross et al., 2000; Kong and Maizels, 2001). Indeed deletions, 
duplications or insertions were found in V genes of germinal-centre B cells. 
Moreover, the idea that DNA breaks occur during SHM is supported by the 
observation (Sale and Neuberger, 1998) that short, non-templated additional bases 
are inserted into a constitutively mutating V gene in a human B cell line (Ramos) 
overexpressing TdT. Two other groups detected double-stranded lesions in V genes 
of B cells undergoing SHM (Papavasiliou and Schatz, 2000; Bross et al., 2000).
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1.4.3.3 Repair
The final step of SHM — repair of the cleaved ends — should be the key step for 
introducing point mutations. Many groups have explored the possible involvement of 
repair enzymes using gene targeting, but the results are confusing. Whereas the 
deficiency of some proteins showed no effect, deficiency of mismatch repair 
proteins including Pms2 (Cascalho et al., 1998; Winter et al., 1998), Msh2 (Bertocci 
et al., 1998; Frey et al., 1998; Rada et al., 1998; Phung et al., 1998) and Mlhl (Kim 
et al., 1999) caused lower mutation frequencies and/or altered mutation spectra. An 
interpretation of all available results has led to two opposing views: either that 
mismatch repair modifies or fixes incipient mutations; or that mismatch repair has no 
role in SHM. However, it is worth noting that Msh2 deficiency affects the efficiency 
and local sequence specificity of both CSR and SHM (Rada et al., 1998; 
Wiesendanger et al., 2000; Schrader et al., 1999; Ehrenstein and Neuberger, 1999). 
Recently, homologous recombination with the sister chromatid was proposed to be 
involved in the repair of double-stranded DNA breaks and in the generation of 
mutations (Papavasiliou and Schatz, 2000). One clear finding, however, is that the 
NHEJ system is dispensable for SHM (Bemark et al., 2000).
Several DNA polymerases have been recently assigned a role in SHM. Polymease 
iota and mu, polymerase zeta and polymerase eta (Dominguez et al., 2000; Zan et al., 
2001; Rogozin et al., 2001).
1.4.4 Activation-induced cytidine deaminase (AID)
During experiment involving complementary DNA subtraction between switch- 
induced and non-induced CH12F3-2 cells, a new protein called activation-induced
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cytidine deaminase (AID) was identified, which is expressed specifically in B cells 
that have been activated in vivo or in vitro. In situ hybridization showed that AID 
expression is restricted to germinal centers, where CSR and SHM take place. 
Overexpression of AID in CH12F3-2 B cells enhanced CSR, irrespective of cytokine 
stimulation. Mice deficient for AID cannot produce IgG, IgA or IgE antibodies, 
whereas IgM is normally (or even more abundantly) produced under immunized or 
non-immunized conditions (Muramatsu et al., 2000). Immunoglobulin classes other 
than IgM and IgD were not detected, even after EPS and cytokine stimulation of 
spleen cells in vitro. Sequence analysis of the VH186.2 V gene in AID-/-mice after 
immunization with 4-hydroxy-3-nitrophenylacetyl (NP) conjugated with chicken- 
globulin (CGG) showed that the mutation frequency was no more than the error rate 
of the Taq polymerase used for the experiment. A mutation in the CD40L gene has 
been shown to cause a condition called X-linked hyper-IgM syndrome type 1 
(HIGMI), which manifests as severe immunodeficiency owing to a defect in CSR 
(Allen et al., 1993; Aruffo et al., 1993; DiSanto et al., 1993; Korthauer et al., 1993). 
There is also another type of HIGM (HIGM2), which shows similar clinical 
symptoms but is inherited in an autosomal-recessive manner (Revy et al., 1998). 
Both the human AID gene and the HIGM2 locus have been mapped to chromosome 
12pl3, and sequencing of the AID coding region from 18 patients with HIGM2 
identified various mutant alleles, all of which would give rise to mutant AID proteins 
with amino-acid replacements or truncations (Revy et al., 2000). Moreover, SHM 
was not observed in B cells from HIGM2 patients. These findings in human and 
mouse convincingly demonstrate the requirement of AID for both CSR and SHM.
In vitro stimulation of B cells from AID-deficient mice with EPS and cytokines 
induced normal germline transcription of downstream S regions. This implies that
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AID is involved in neither signal transduction from the cell-surface receptor to the 
nucleus, nor in the establishment of the accessible state of the S region. V(D)J 
recombination is normal in humans and mice with the AID mutation, indicating that 
AID is not involved in the repair process that is shared between V(D)J recombination 
and CSR. In other words, AID is probably involved in the cleavage step during CSR. 
The predicted amino-acid sequence (198 residues) of AID has homology to that of 
APOBEC-1, which is a catalytic subunit of the RNA-editing complex for the 
apolipoprotein B messenger RNA precursor (Chester et al., 2000). APOBEC-1 
converts the specific cytosine at position 6666 of apolipoprotein B mRNA to uracil 
by its intrinsic cytidine deaminase activity, giving rise to mRNA that encodes the 
CHYLOMICRON component. Although APOBEC-1 cannot bind a specific 
sequence in the target mRNA, this specificity is conferred by a protein with which it 
associates, APOBEC-1 complementation factor (ACT) (Mehta et al., 2000). Like 
APOBEC-1, AID synthesized in vitro has cytidine deaminase activity. Moreover, 
both the APOBEC-1 and AID genes are closely mapped to human chromosome 
12pl3. These structural, genetic and functional relationships of AID and APOBEC-1 
indicate that AID might be an RNA-editing enzyme. AID, in a complex with an 
ACE-like protein, might edit a certain mRNA, giving rise to a new mRNA that 
encodes the class-switch recombinase.
1.4.5 Differentiation into memory cells or plasma cells
After isotype switching and SHM, selected germinal center B cells are subject to 
differentiative signals that drive cells into one of two fates: to become plasma cells or 
memory cells (Fig. 1.5) (Klinman, 1996; Liu et al., 1997). Differentiation into
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plasma cells results in a switch from generation of predominantly membrane-bound 
Ig to high level production of secreted Ig. Plasma cells produce the vast majority of 
circulating antibodies. In contrast, memory cells represent long-lived high-affinity 
resting cells. On rexposure to target antigen these primed cells are able to rapidly 
amplify and differentiate generating large numbers of Ig-secreting plasma cells. 
Unlike plasma cell differentiation in a primary immune response, plasma cell 
differentiation from memory derived precursors does not involve germinal center 
formation.
Some of the factors regulating these developmental pathways have been identified. 
The CD40 receptor, among its several other roles in B cell development, has been 
implicated as a key regulator of the differentiation branch point between memory and 
plasma cells (Arpin et al., 1995) (Lane et al., 1995; Callard et al., 1995). In addition a 
number of cytokines have been implicated in regulating differentiation pathways of 
activated B cells.
1.4.6 Regulation of lymphocyte survival during B-cell development
The lymphoid immune system exists in a state of dynamic homeostasis, with rapid 
clonal expansion and massive cell turnover in almost all phases of development. 
Turnover results from induction of apoptosis in the vast majority of lymphocytes and 
lymphoid progenitors. The apoptotic pathway attenuates immune responses and 
eliminates autoreactive cells. Deregulation of apoptosis has been associated with 
immunodeficient states, lymphoma, and autoimmune disease (Rudin and Thompson, 
1997).
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Bcl-2 was the first identified member of an expanding family of apoptotic regulators 
(Tsujimoto and Croce, 1986). The t( 14; 18) translocation found in 85% of follicular B 
cell lymphomas juxtaposes the Bcl-2 gene with the IgH enhancer, resulting in 
constitutive overexpression of Bcl-2 and expansion of the mature-appearing B cells 
characteristic of this disease. Bcl-2 family members may also play important roles in 
normal lymphocyte maturation. Expression of Bcl-2 and the related apoptotic 
inhibitor Bcl-xL are differentially regulated during B cell development (Merino et 
al., 1994) (Grillot et al., 1996). Bcl-xL is expressed in developing pre-B cells, and 
may be essential for survival through this period of clonal selection. Bcl-2 is 
expressed in pro-B cells, downregulated during the pre-B cell stage, and re-expressed 
in mature B cells. Neither Bcl-2 nor Bcl-xL appears to be expressed during the 
immature B cell stage during which deletion of autoreactive naive B cells occurs. 
Bcl-2 expression s appears to be critical in mature B cell, as homozygous disruption 
of the Bcl-2 gene results in relatively normal lymphoid development but progressive 
loss of the mature B lymphoid immune system (Nakayama et al., 1993) (Veis et al.,
1993). Finally, Bcl-xL, but not Bcl-2, is strongly upregulated during B cell 
activation, and may be essential for the survival and expansion of the responding 
population.
Progression through the sequential stages of pre-B cell development requires a series 
of positive survival signals dependent on the production of appropriate membrane- 
bound receptors. Inability to generate a functionally rearranged IgH gene results in 
developmental arrest and apoptosis in the majority (perhaps 90%) of B cell 
precursors. Similarly, failure to generate a functional IgL able to pair with the IgH as 
surface Ig results in apoptosis and further reduction in B cell precursors. Newly 
generated B cells producing an autoreactive IgM are eliminated by apoptosis before
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leaving the bone marrow. Only a small fraction of the B cell precursors generated 
survive to constitute the peripheral immune system.
In the absence of positive stimulation, peripheral lymphocytes are also highly 
susceptible to apoptotic induction. Unless rescued by exogenously added cytokines, 
peripheral lymphocytes undergo apoptosis within hours of removal from the body. 
Unstimulated lymphocytes in vivo survive on average only a few days in the 
periphery, dying again by apoptosis.
A complex interplay of cell death signals directs germinal center selection (Liu et al., 
1997). Lymphocyte activation is associated with dramatic increases in both 
proliferation and apoptotic sensitivity. The priming of germinal center B cells for 
apoptosis reflects the upregulated expression of several factors involved in apoptotic 
induction, including c-Myc, p53 and Fas (Martinez-Valdez et al., 1996). High level 
expression of c-Myc in particular is associated with both marked proliferative 
induction and hightened apoptotic sensitivity.
Understanding the pathways between cell surface receptors and the intracellular 
apoptotic regulators has been a major focus of recent research on lymphocyte 
activation. A number of cell surface receptors related to the TNF receptors have been 
found to play critical roles in regulating lymphocyte survival. Of particular 
importance in B cell survival are the CD40 and Fas receptors (Rathmell et al., 1996; 
Goodnow, 1996). CD40 interacts with the CD40 ligand expressed on the surface of T 
cells and conducts a critical costimulatory signal in T cell-dependent B cell 
activation. Ligand binding to the Fas receptor, in contrast, generates a potent 
apoptotic signal in lymphocytes. Survival of germinal center B cells depends on at 
least two signals, generated by productive engagement of the receptor and the CD40 
receptor. After SHM, generation of high affinity Ig receptors is required for the first
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signal. Antigen processing and presentation by high affinity B cells to germinal 
center T cells may in turn trigger presentation of the second signal, the CD40 ligand 
on the surface of activated T cells. B cell stimulation through both the surface Ig and 
CD40 receptors results in activation, proliferation, and a transient resistance to Fas 
mediated death. In contrast, CD40 engagement in the absence of antigen recognition 
by the Ig receptor does not results in activation or proliferation but heightens 
susceptibility to Fas mediated apoptosis. The requirement for cooperative interaction 
between antigen-specific B and T cells may help to ensure selectivity and specificity 
in the immune response.
Ultimately, the vast majority of the selected high affinity B cell clones amplified by 
an immune response undergo massive apoptosis in the termination of that response. 
Factors involved in the loss of apoptotic resistance in this process may include 
elimination of the antigenic stimulus, loss of costimulatory signals, and the delayed 
expression of additional factors (such as CTLA-4 on activated T cells) that interrupt 
the costimulatory feedback loop between activated B and T cells. Only a minute 
fraction of the activated population persists as memory cells.
1.5 Origin and history of B cell tumors as revealed by analysis of 
immunoglobulin genes
Since the Ig locus plays a fundamental role in the development of B cell tumors Ig- 
gene status has become an indicator of the tumors’ cell of origin. Normal B-cell 
differentiation is characterized by a series of regulated DNA rearrangements and 
neoplastic events can occur at many points. Briefly, peripheral B-cell maturation can 
be divided into 3 stages. In the first stage (pre-GC stage) the naive B cell has not yet
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encountered the antigen. In the second stage (GC stage) SHM and isotype switching 
can occur, following entry into a GC of the peripheral lymphoid tissue (Berek, 1992; 
Kelsoe, 1995). In the GC, B cells encounter T cells and antigens presented on 
dendritic cells and produce high affinity antibodies. Unselected cells die of apoptosis. 
In the third stage (post-GC stage), memory B cells may recirculate or home to the 
antigen draining sites. Alternatively B cells may differentiate to plasma cells (Klein 
et al., 1997; Dunn-Walters et al., 1995) (Figure 1.7).
The natural DNA rearrangement occurring during V(D)J recombination or CSR 
renders chromosome 14 vulnerable to translocations and other rearrangement events 
(Rabbitts, 1994). Similarly chromosome 2 and 22 may be involved. A further 
influence on tumor development derives from SHM which targets V(D)J sequences 
and surrounding translocated genes (Yelamos et al., 1995; Cook and Tomlinson, 
1995).
Each tumor carries its variable genes (V genes) as clonal markers and these, 
identified and sequenced, allow the assignment to histopathological or clinical tumor 
categories. Identification of clonal V genes in tumors has implications for diagnosis, 
monitoring and treatment (Matsuda et al., 1993). Importantly, V gene sequences will 
indicate whether the cell of origin has undergone affinity maturation under the 
influence of an antigen. The accumulation of somatic mutations in the Vh genes 
indicates that the cell has been exposed to the hypermutation mechanism and 
therefore must have entered or passed through the GC (Du et al., 1996; Berek et al., 
1991; Hummel et al., 1994; Rajewsky, 1996; Bahler et al., 1991; Levy et al., 1987). 
The detection of intraclonal diversification allows discrimination between GC B 
cells, which show non-common mutations, and post GC B cells which do not 
(Kuppers et al., 1993).
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When somatic mutations are detected it is important to define if they are determined 
by the presence of an antigen. This can be done by studying the distribution of 
replacement amino acids in the IgH V genes and can be informative since the antigen 
could drive the proliferation of the tumor (Bahler and Levy, 1992). Preferential V 
gene usage can reveal a possible role for superantigens which can bind to unmutated 
framework regions (Li et al., 1996; Silverman, 1992).
As the study of V genes gives important information on the maturation of the 
tumor’s cell of origin, even the study of IgH switch regions can give similar 
information. It is possible to distinguish cells which have not entered the GC and 
cells which have entered or passed the GC. The first are “naive” cells and the second 
are mature or “experienced” cells. Not all experienced cells have undergone CSR 
(i.e. cells with IgM isotype) but the study of IgH switch regions can still give anyway 
important information. Frequently, B cells are not able to undergo a complete CSR 
with isotype exchange (from M to G,A,E) but carry genomic alterations in the switch 
regions which will indicate an attempt of the cell to undergo CSR.
1.6 Mucosa-Associated Lymphoid Tissue (MALT) lymphomas
Mucosa-Associated Lymphoid Tissue (MALT) lymphomas originate from native or 
acquired MALT. Native MALT is physiologically present whereas acquired MALT 
develops in sites of inflammation in response to infections such as H e l ic o b a c te r  
p y l o r i  gastritis, or autoimmune processes such as myoepithelial sialadenitis 
associated with Sjogren’s syndrome or Hashimoto’s thyroiditis. In this context a 
pathological clone can replace the normal lymphoid population and give rise to 
MALT lymphoma. MALT lymphoma shows the features of primary extranodal
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lymphomas that arise outside the lymph nodes and constitute between 25% and 40% 
of malignant non-Hodgkin’s lymphoma. MALT lymphomas can arise from 1) 
Extranodal lymphoid organs such as the spleen; 2) Non-lymphoid organs containing 
a native lymphod tissue such as the gastrointestinal tract; 3) Organs normally devoid 
of lymphoid tissue such as the brain. Clinicopathologic features of MALT 
lymphomas show that these lymphomas are more closely related to the structure and 
function of MALT than to peripheral lymph nodes.
1.6.1 MALT lymphoma main features
In 1980, Isaacson and Wright defined a morphologically and clinically homogeneous 
group of lymphomas (Isaacson and Wright, 1984). They tend to remain localized for 
long periods and seldom involve the bone marrow at presentation. These lymphomas 
are often preceded by infections that induce acquired MALT and most commonly 
occur in the stomach but also in the intestine, salivary gland, respiratory tract, 
thyroid, ocular adnexa, thymus, liver, genitourinary tract, breast and skin.
1.6.2 Low-grade MALT lymphoma histology
Histologic features of low-grade MALT lymphoma closely simulate those of the 
Peyer’s patches. Lymphoma infiltrates around reactive follicles and spreads into the 
surrounding mucosa. Tumor cells resemble follicle center centrocytes, small 
lymphocytes or monocytoid B cells and form lymphoepithelial lesions by invasion of 
individual glands. Often it is possible to find transformed blasts, plasmacell 
differentiation and follicular colonization, all histologic features suggesting that the
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lymphoma cell participates in an immune response. Involvement of gastric lymph 
nodes occurs in about 30% of cases (Montalban et al., 1995). In these cases the 
lymphomatous infiltrate extends to form confluent sheets with eventual replacement 
of the node
1.6.3 High-grade MALT lymphoma histology
In addition to transformed blasts, it is possible to find in low-grade MALT 
lymphoma foci of high-grade transformation characterized by confluent clusters of 
transformed blasts (De Jong et al., 1997). Isolated foci of typical low-grade MALT 
lymphoma can be found in high-grade cases, indicating the possibility for low-grade 
to transform into high-grade. In the absence of low-grade features, it is very difficult 
to differentiate high-grade MALT lymphomas from other high-grade B cell tumors. 
Only the characteristic lymphoepithelial lesions may be found. High-grade cells may 
resemble centroblasts or plasmablasts and sometimes may present numerous 
multinucleated forms. The close association with H p y l o r i  infection and the absence 
of Bcl2 rearrangements may contribute to the classification of high-grade MALT 
lymphoma.
1.6.4 Immunophenotype
B cells of MALT lymphoma express surface immunoglobulin, usually of the IgM 
isotype, which shows light-chain restriction (Griffin et al., 1992). Demonstration of 
this restriction supports the diagnosis of B-cell lymphoma. They are CD5-, CD 10-, 
CD23- and CD 19+, CD20+, CD79a+ (pan-B antigens) CD21+ (follicular dendritic
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cells) and CD35+. Bcl2 expression is present only in low-grade and Cyclin D1 is 
always absent. This phenotype is homologous with that of marginal zone B cells. 
Indeed in the Revised European-American Lymphoma (R.E.A.L) classification the 
marginal-zone B cell is recognised as the normal cell counterpart of MALT 
lymphoma (Harris et al., 1994). Abundance of CD4+ T-cells is often evident in low- 
grade but not high-grade, supporting the theory that T-cell help is necessary for the 
initial tumor growth and that the antigen may play a fundamental role.
1.6.5 MALT lymphoma of the stomach and Helicobacter pylori
MALT lymphoma of the stomach is preceded by the acquisition of MALT as a result 
of H . p y l o r i  infection and several pieces of evidence suggest a link between H . 
p y lo r i - c h r o m c  gastritis and the outgrowth of lymphoma (Zucca et al., 1998; 
Wotherspoon et al., 1991). Infection of the stomach with H  p y l o r i  leads to the 
accumulation of lymphoid tissue in the gastric mucosa where B cell follicles are 
characteristically present. Epidemiologic studies report an association between H . 
p y l o r i  infection and gastric malignancies, lymphomas (Doglioni et al., 1992; 
Parsonnet et al., 1994; Vineis et al., 1999) and carcinomas (Parsonnet et al., 1991) 
(90% of these malignancies are H . p y l o r i  positive). In vitro neoplastic cells of MALT 
lymphoma proliferate in the presence o f  H  p y l o r i  through the activation of T cells. In 
one case it was demonstrated that splenic T-cells from the same patient did not 
respond to the stimulating strain of H  p y lo r i ,  demonstrating that the T population 
responsive to H . p y l o r i  was local. This explains also why gastric MALT lymphomas 
in the early phase remain localized. Specimens of gastritis infected by H . p y l o r i  
revealed the presence of the neoplastic B cell clone several years before the
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development of lymphoma (Zucca et al., 1998). The progenitor of the neoplastic B 
cell clone must have some genetic alteration or abnormal biological property that 
results in its uncontrolled proliferation in the presence of T-cell help. Finally 
regression of MALT lymphoma after antibiotic eradication of H . p y l o r i  has been 
reported in a high number of cases by several independent groups (Montalban et al., 
1997; Steinbach et al., 1999). Antibiotic therapy appears to be effective only in low- 
grade disease restricted to the mucosa or submucosa.
1.6.6 Genetic evidence for a role of the antigen in the development of MALT 
lymphomas
Immunoglobulin genes expressed by MALT lymphomas show extensive SHMs with 
evidence in some cases of intraclonal variation. This strongly suggests that direct 
antigen stimulation plays a role in clonal expansion of the tumor (Du et al., 1996) 
which is well in keeping with the presence of infectious or autoimmune processes. 
Further evidence for antigen driven selection is the usage of unusual immunoglobulin
V-D-J rearrangements to generate antibody diversity and antigen-binding affinity. In 
two patients the third complementarity determining region (CDR3) amino acidic 
sequence was identical, suggesting the presence of a common selecting antigen 
(Bertoni et al., 1997). The dependence on the antigen and on the local immune 
response explains the tendency of MALT lymphoma to remain localized, although 
cases trasforming into aggressive disseminating forms have been described (Zucca et 
al., 1998). Antigenic stimulation gives a growth advantage to the B cell clone that 
can respond and that can become predominant and more susceptible to genetic 
alterations resulting in trasformation and progression (Ghia and Nadler, 1997).
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1.6.7 Genetic features of MALT lymphomas
The most common chromosomal translocation is the t(ll;18)(q21;q21) present in a 
third of eases (Auer et ah, 1997). Recently the genes at the transloeation breakpoints 
were identified as the apoptosis inhibitor gene API2 on eh. 11 and MALTl on ch. 18. 
In this transloeation, a fusion gene is created which encodes a chimeric protein 
consisting of the N-terminal portion of API2 linked to the C terminus of the novel 
protein MALTl. MALTl contains a caspase-like domain in the C terminus but no 
physiologic function has been ascribed to this protein.
A second non-random transloeation more rarely detected is the t(l;14)(p22;q32) 
which results in the transfer of the entire Bel 10 gene to chromosome 14. In this 
location Bel 10 is stimulated by the strong IgH enhancer (Willis et al., 1999). Bel 10 
and MALTl form a tight complex which serves to oligomerize and activate the 
caspase-like domain of MALTl. This appears to activate the downstream IkB kinase 
complex (IKK) leading to the induction of NF-kB. Also the API2-MALT1 fusion 
protein activates NF-kb in the same way, showing dependence upon the same 
downstream signaling factors. Therefore a model has been proposed where both 
products of independent translocations activate a common downstream signaling 
pathway that originates with the activation of the caspase-like domain.
Trisomy 3 was previously reported as a very frequent abnormality in MALT 
lymphomas, but more recent studies revealed a much lower ineidenee(Wotherspoon 
et al., 1995; Ott et al., 1998; Hoeve et al., 1999). Bell and BcI2 are not rearranged in 
MALT lymphomas (Wotherspoon et al., 1990; Clark et al., 1992) and Bcl6 only 
rarely (3/34 cases) (Dierlamm et al., 1997). c-myc is commonly mutated in the exon 
I/Intron I regulatory region (7/54 cases) (Peng et al., 1997). Microsatellite 
instability was reported in about 50% of eases (Peng et al., 1996) although other
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groups were not able to confirm these data (Sol Mateo M. et ah, 1998; Xu et al., 
1998; Furlan et al., 1999; Hoeve et al., 1999). p53 shows loss of heterozygosity in 
7% of LG and 29% of HG MALT lymphomas while mutations in p53 were observed 
in 19% of LG and 33% of HG (Du et al., 1995; Neumeister et al., 1997; Martinez- 
Delgado et al., 1997).
Studies of tumor-derived rearranged Vh genes demonstrated the presence of somatic 
mutations with evidence of intraelonal diversification, i.e. non-eommon mutations, in 
some cases (Qin et al., 1997; Qin et al., 1995).
1.6.8 Model for the pathogenesis of gastric MALT lymphoma
It is likely that some of the above described chromosomal abnormalities provide a 
selective growth advantage to malignant cells. However, a possible explanation for 
the pathogenesis of gastric MALT lymphoma may be the following. T cells are 
activated in the gastric mucosa by H . p y l o r i  and cytokines and cause a secondary 
proliferation of B cells. These neoplastic B cells produce antibodies specific for 
autoantigens and need help from T cells to proliferate. This help is apparently 
mediated by CD40 and CD40L interactions (Hussell et al., 1996; Greiner et al.,
1997). This dependence on T cells help may explain the tendency of LG MALT 
lymphoma to remain localized and to regress after H . p y l o r i  eradication. Possibly 
genetic alterations continue until autonomous growth is reached and later 
transformation to HG lymphoma can occur. The mechanism of progression from H  
p y l o r i  infection to LG and HG lymphoma is still unclear since for example most 
patients with H . p y l o r i  gastritis do not develop lymphoma; therefore additional
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environmental, mierobial and host genetic factors play a role in lymphomagenesis 
(Go, 1997; Covaeei et ah, 1999).
1.6.9 Diagnosis, staging and therapy
The most common symptoms of LG-MALT lymphoma are nonspecific dyspepsia 
and epigastric pain caused by nonspecific gastritis or peptic ulcer. A few patients 
present with elevated lactate dehydrogenase (LDH) or p2-mieroglobulin levels. The 
best staging system is still controversial but numerous groups adopt the revised 
version of the Blaekledge staging system, recommended by an international 
workshop held in Lugano in 1993. Unlike most LG B-cell lymphomas of peripheral 
lymph nodes LG MALT is usually very indolent and often remains localized for 
prolonged periods; in some cases no progression is seen during several years without 
treatment. Systemic dissemination and bone marrow involvement occur rarely 
(Cogliatti et ah, 1991; Montalban et ah, 1995).
It is difficult to determine what is the best therapy for MALT lymphomas because of 
the insufficient staging of older reports and more recent studies have been based on 
retrospective series. Eradication of H  p y l o r i  with antibiotics can be effectively 
employed as the sole initial treatment (Montalban et ah, 1997; Steinbaeh et ah, 1999; 
Saekmann et ah, 1997; Weston et ah, 1999; Savio et ah, 1996; Nobre-Leitao et ah,
1998). Patients which do not respond to H . p y l o r i  eradication may have harboured 
HG lesions that initially had not been recognized (Neubauer et ah, 1997). This would 
support the hypothesis of a clonal evolution fi*om a LG MALT still dependent on T- 
eell help, to an autonomous LG MALT and eventually to an HG MALT, neither 
requiring antigenic drive for survival and growth. The use of antibiotics as first-line
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therapy may postpone the necessity for surgical resection in most patients, and a 
strict endoscopic followup is therefore recommended (Zueca and Cavalli, 1996). In 
ease of unsuccessful H . p y l o r i  eradication, triple or quadruple therapy of proton 
pump inhibitor plus antibiotics should be attempted (Hunt, 1997; Malfertheiner et al., 
1997). Patients presenting deep infiltration of the gastric wall or nodal involvement 
should receive chemotherapy or radiotherapy in addition to antibiotic therapy 
(Steinbaeh et al., 1999). No treatment guidelines exist for the management of patients 
after antibiotic therapy and nonpublished randomized studies may help in this 
decision. Finally, if surgery is chosen, a total gastrectomy may offer greater chances 
of cure even though this operation may impair the patient’s quality of life.
1.7 B cell Chronic Lymphocytic Leukemia (B-CLL)
B-CLL is the most common leukemia in the Western world and it is characterized by 
the accumulation of monoclonal B cells resembling small mature lymphocytes with a 
typical immunophenotype. B-CLL has been extensively studied as model to explain 
the cellular properties of normal B cells although its cells are so distinctive that the 
analogies are inappropriate. First, B-CLL is the only blood malignancy not 
associated with exposure to toxic drugs and chemicals (Hamblin and Oseier, 1998). 
Second, it is the best example of a human malignancy that involves defects in the 
induction of programmed cell death. Indeed the gene setting is optimally organized 
to avoid apoptosis. Last, B-CLL patients have a high prevalence of autoimmune 
phenomena (autoAb production) causing cytopenias and hypogammaglobulinemia 
(Kipps and Carson, 1993) (Rozman and Montserrat, 1995).
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1.7.1 Phenotype of malignant B-CLL cells
The immunophenotype of malignant B cells closely resembles that of mantle zone 
lymphocytes of secondary lymphoid follicles (Caligaris-Cappio and Janossy, 1985). 
They express most of the antigens characteristic of mature B cells and they coexpress 
CD5 and faint monoclonal surface immunoglobulins (sigs). These sigs are usually 
sIgM+/- sIgD and only rarely sIgG or sIgA (Hashimoto et al., 1995) that often have 
polyreactive autoAb activity (Boumsell et al., 1978; Temynck et al., 1974). Surface 
Igs frequently behave as a rheumatoid factor (Preud'homme and Seligmann, 1972; 
Borche et al., 1990; Sthoeger et al., 1989). Indeed there is evidence of overusage of
V I-69 in germline configuration that codes for monoclonal rheumatoid factor. This 
faint sIg/CD5 coexpression serves to distinguish B-CLL from other small cell 
lymphomas (Harris et al., 1994) and provides a clue about the cell of origin. Low 
levels of sIgM are seen only in normal B cells anergized by interaction with self 
antigens (Goodnow et al., 1988) and normal CD5+ B cells of the mantle zone often 
produce polyreactive, low affinity autoAbs (Caligaris-Cappio et al., 1982; Casali and 
Notkins, 1989). Therefore these similarities have generated the hypothesis that B- 
CLL is a malignancy of mantle zone anergic self-reactive CD5+ B cells devoted to 
the production of polyreaetive natural autoAbs (Caligaris-Cappio, 1996). The ability 
to produce autoAbs may provide a survival advantage for the leukemic cells because 
the interaction of autoreactive sigs with their self Ags has been shown to prevent the 
apoptosis of the malignant cell. Atypical eases represent deviations from the 
orthodoxy of a single entity indicating that B-CLL includes different forms not yet 
fully identified.
Most circulating B-CLL lymphocytes are in the Go phase of the cell cycle (Andreeff 
et al., 1980), and because of the abnormalities of the BCR are insensitive to
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mitogenic signals that induce the proliferation of normal B cells (Nilsson, 1992). The 
BCR is a complex formed by the sig and the Iga/Igb (CD79a/CD79b) heterodimer 
that translates the Ig engagement into the biochemical signals that drive the B-eell 
response (Reth, 1992). Different abnormalities of BCR determine its low expression 
on B-CLL cells which may account for the defective signal transduction via the BCR 
and the reduced induction of protein tyrosine kinase activity (Lankester et al., 1995). 
Other molecules which normally transduce signals in B cells for example, CD22 
induced by anti Ig and CD21 induced by EBV, are weakly expressed on B-CLL cells 
(Clark and Lane, 1991; Matutes et al., 1994; Rickinson et al., 1982). Eventually B- 
CLL cells have a marked reduction of functional Na+/H+ antiporter units which 
respond to EPS proliferative stimuli (Ghigo et al., 1991). Note that B-CLL cells 
produce many cytokines but none of these is individually able to overcome the Go 
blockade. Their role in the natural history of B-CLL is still unclear.
1.7.2 Molecular abnormalities
It has been extremely difficult to define the molecular abnormalities in B-CLL for 
two reasons: the very low mitotic rate and the usage of mitogens that stimulated T 
cells and not B cells. An abnormal karyotype is observed in approximately 50% of 
patients (Juliusson et al., 1990). The most frequent abnormalities are deletions or 
transloeations of eh. 13ql4 (Fitchett et al., 1987), trisomy 12 (Han et al., 1984) and 
deletions of ch. 1 lq23 (Dohner et al., 1997) and 6q (Offit et al., 1993). About half of 
the patients have a single abnormality and the remainder have two abnormalities or a 
more complex pattern.
55
The most frequent abnormality is that of chromosome 13ql4 and patients with it 
have a benign disease and survive as long as their matched controls (Oseier et ah, 
1990). In contrast, trisomy 12 is associated with progressive disease (Oseier et al.,
1997) and atypical cellular morphology (Matutes et al., 1996). Trisomy 12 
determines MDM2 gene amplification and overexpression with inactivation of p53. 
Moreover trisomy 12 is associated with unmutated VH genes, whereas CLLs with 
13ql4 deletions show heavy somatic mutations (Oseier et al., 1997). Deletions at 
llq23 are found in up to 10% of CLLs and patients with this abnormality are 
reported to have extensive lymphnode involvement and require an aggressive clinical 
course (Dohner et al., 1997). Mutations or deletions of p53 at 17pl3 occur in 15% of 
patients and are associated with advanced disease, high proliferation rate and 
shortened survival (Lens et al., 1997). t(14;18) is rare (Dyer et al., 1994) but BcI2 is 
overexpressed (Pezzella et al., 1990; Schena et al., 1992) probably because of 
hypomethylation causing increased RNA transcription (Hanada et al., 1993). B-CLL 
cells express high levels of Bel2, BelxL and Bax (Gottardi et al., 1996). Bax is a 
partner for Bcl2 and Bcl-xL synergizes with Bcl2. In B-CLL there is no Fas 
expression (Mapara et al., 1993) and no c-myc expression (Larsson et al., 1987), 
both proapoptotic molecules. This pattern of expression favours the suppression of 
apoptosis. Bcl3 transloeations, t(14;19), are rarer than t(14;18) and in 50% of cases 
are associated with trisomy 12 (Michaux et al., 1997).
1.7.3 Immune deficiency and autoimmunity in B-CLL
Immune incompetence is a cardinal feature of B-CLL. At the time of diagnosis most 
B-CLL patients show expansion of the T cell mass and normal Ig levels, particularly
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in an early stage of disease. After having received treatment they show deficiency of 
T cell function with inversion of the CD4 to CDS ratio and low immunoglobulin 
levels (Bartik et al., 1998; Chapel, 1987). B-CLL cells secrete TGF-B, which is a 
potent inhibitor of B-cell proliferation (Lotz et al., 1994), and release high levels of 
circulating IL-2 receptor (Semenzato et al., 1987), which might act as a sponge for 
endogenous IL-2 and thus down-regulate the T helper function. Furthermore, B-CLL 
cells fail to present soluble antigen and alloantigen (Dazzi et al., 1995; Eris et al.,
1994), whereas normal, activated B cells are very effective APCs (Lanzavecchia, 
1985). The inability of B-CLL cells (and of anergic normal B cells) to properly act as 
APCs is explained, at least in part, by the low levels of sIg and the suboptimal 
expression of the eostimulatory molecules CD80 and CD86. The defective 
expression of CD79b may be an additional element. It should also be considered that 
CLL CD4+ T cells express CD40 ligand (CD 154) mRNA but fail to express the 
molecule on the cell surface after CD3 ligation. CD40+ leukemic cells have been 
shown to down-modulate CD 154 on the surface of normal, donor-activated CD4+ T 
cells, provided that the ratio between CD4+ normal T cells and leukemic B cells 
declines below a critical level (Cantwell et al., 1997). In a disease characterized by 
an excess of CD40+ leukemic cells, such a receptor-mediated down-modulation of 
CD 154 could interfere with the ability of normal T cells to interact with normal B 
cells or other APCs. Moreover given the role of CD 154 in T cell induction of isotype 
switching this defect in CD 154 may account for the deficiency of CLL patients to 
produce IgG of various subclasses (van de Velde et al., 1991). The conclusion to be 
drawn from all these data is that the accumulating malignant B-eell population per se 
is a hurdle obstructing the production of normal antibody and may lead to 
progressive immunoincompetence.
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Any explanation of the immunodeficiency has to be consistent with the fact that up 
to 25% of patients develop autoimmune syndromes like hemolytic anemia, 
thrombocytopenia, and, more rarely, neutropenia or pure red cell aplasia (Hamblin et 
ah, 1986). In the vast majority of eases, the autoAbs are polyclonal and, by 
definition, not produced by the malignant clone (Kipps and Carson, 1993). The 
production of polyclonal, monoreactive, high-affinity, pathogenic autoAbs of IgG 
class in the context of a malignancy characterized by the accumulation of anergic B 
cells that produce monoclonal, polyreactive, low-affinity autoreaetive IgM antibodies 
is an obvious paradox. Two other facts need to be accommodated by any global 
theory. First, autoimmunity in B-CLL is almost entirely confined to an attack on the 
formed elements of the blood (Kipps and Carson, 1993; Hamblin et al., 1986). 
Second, autoimmunity is much more common in patients treated with fludarabine, a 
drug known to induce profound suppression of circulating CD4+ T cells (Myint et 
al., 1995).
It is not unreasonable to suppose that immune incompetence and autoimmunity are 
two sides of the same coin. A common explanation of these immune defects may lie 
in aberrations of the immunoregulatory circuits that involve the malignant B cells as 
well as the T cells and residual normal B cells. One of these abnormalities may well 
be the role of B-CLL cells as APCs. In vitro experiments have shown that 
stimulation of CD40 on the membrane of B-CLL cells (as well as on anergic normal 
B cells) by the T cell-expressed CD 154 may up-regulate the surface expression of 
CD80 and CD86 molecules and thus transform anergic CD80-CD86- cells into 
efficient CD80+CD86+ APCs (Eris et al., 1994; Ranheim and Kipps, 1993). The role 
of malignant B cells as APCs is underscored by experiments with severe combined 
immunodeficiency mice: when reconstituted with peripheral blood lymphocytes from
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CLL patients (Kobayashi et al., 1992), they frequently develop polyclonal human 
IgG autoAbs to human redblood cells even though the CLL itself does not proliferate 
within the mouse. Further complexity is added to the system by the reeent report that 
CLL malignant B eells can express CD 154 and may demonstrate a T cell-type 
eo stimulatory capacity that provides inappropriate B-eell "help"(Schattner et al.,
1998).
Another eceentrieity may lie in the Ig gene usage of the CLL cells. In patients with 
autoimmune hemolytic anemia, it has been suggested that a particular CDR3 region 
is used by the leukemic eells (Efremov et al., 1996). This implies that the antibody 
used may beinvolved in the pathogenesis of the hemolytic anemia, perhaps by 
promoting an increased clearance of senescent enterythrocytes.
Finally, T-cell numbers are increased in B-CLL patients (Kay, 1981) and have 
profound abnormalities of their antigen receptor (TCR) repertoire (Serrano et al., 
1997). If we assume that certain T-cell subsets are able to prevent the development of 
autoreaetive B cells, it follows that when these T-cell subsets are absent, eg, after 
treatment with purine analogs, autoreaetive B-cell clones may easily emerge and 
expand. B-CLL cells may become activated by T helper cells (perhaps via CD 154 if 
an adequate T cell to malignant B cell ratio is maintained) in an environment such as 
the spleen, where senescent anucleate blood cells are removed. Such activated 
malignant B eells may then become able to present red cell and/or platelet membrane 
degradation products (self-Ag) and drive residual normal B eells to produce target- 
restricted pathogenic autoAbs (Caligaris-Cappio, 1996). This process would be 
facilitated if the B-CLL cells used certain Ig genes and might become clinically 
evident when the control exerted by T eells becomes deficient.
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Finally, constitutive expression of FasL on B-CLL cells, inducing apoptosis on T 
cells, is proposed as a mechanism for decreased absolute T cell count and inverted 
CD4 to CD8 ratio.
1.7.4 Immunoglobulin genes: “switch” and “variable” region configuration
As previously reported, B-CLL eells express low-density surface immunoglobulins, 
most often of IgM or IgM/IgD isotype. Only a small proportion of B-CLL is 
characterized by the expression of isotype-switched immunoglobulins (Keating, 
1999; Hashimoto et al., 1995).
Rearrangements in the immunoglobulin Sp regions without productive isotype 
switching have been observed in B-CLL cases. Crossen e t  a l  found in 31% of B- 
CLL rearrangements of the Cp-switch region that could not be explained by normal 
rearrangements of the immunoglobulin genes. The molecular nature and the clinical 
implications of these alterations were not investigated (Crossen and Morrison, 1998). 
Studies by Hakim e t  a l  detected rearrangements of the Jh-Cp intron in about 40% of 
B-CLL eases but only one rearranged fragment was cloned revealing a 300 bp 
insertion in the Sp region (Hakim et al., 1993).
In addition to rearrangements of the switch regions, B-CLL slgM^ eells also show a 
capacity to undergo isotype switching in  v i tr o  when stimulated through surface 
CD40 in the presence of ILIO (Malisan et al., 1996). Moreover studies by Fais e t  a l  
reported the presence of Ca and Cy transcripts bearing the same Vh region of the 
IgM in 50% of IgM^CLL patients (Fais et al., 1996) and studies by Efremov e t  a l  
reported the presence of Ca and Cy transcripts in all analyzed cases even though only 
2% of the population expresses sIgG on FACS analysis (Efremov et al., 1996).
60
Under physiological conditions, isotype switching occurs in temporal correlation 
with somatic mutation of the variable genes in the germinal center microenvironment 
(Gearhart et al., 1981; Siekevitz et al., 1987; Siekevitz et al., 1987) and the reeent 
discovery of AID (Activation-Induced Cytidine Deaminase) (Kinoshita and Honjo, 
2001) has revealed an unexpected link between isotype switch recombination and 
somatic hypermutation. This does not imply that a mutated B-CLL is also isotype- 
switched or vice versa. Indeed, these somatic processes can occur independently, and 
there is evidence suggesting that variable gene somatic mutation already occurs in 
IgM of the late primary response before isotype switch (van Es et al., 1992), and that 
isotype switching can occur in the absence of somatic mutations (Wysoeki et al., 
1992; Gilmore et al., 1987; Gilmore et al., 1987).
Traditionally B-CLL has been viewed as a tumor of “naïve” B eells possibly arising 
in the follicular mantle zone (Caligaris-Cappio, 1996). However, some B-CLL with 
somatically mutated immunoglobulin variable region genes have been described 
(Schroeder and Dighiero, 1994). Since somatic mutation is believed to occur in 
germinal centers (Berek and Milstein, 1987), the presence of such mutations 
indicates that the cell of origin has passed through the germinal center. Thus, it has 
been suggested that B-CLL comprises two different disease subtypes, one arising 
from a “naïve” B cell, the other from a “memory” B cell. Patients with non-mutated 
variable genes have a distinctly more malignant disease and a much shorter survival 
than those with somatic mutations (Maloum et al., 2000; Hamblin et al., 1999).
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1.7.5 Staging systems and prognostic factors
The Rai and Binet staging systems have provided the backbone of clinical staging 
(Rai et ah, 1975) (Binet et al., 1981). Rai system divides B-CLL eases in 5 stages (0, 
I, II, III, IV) while Binet in 3 stages (A, B, C). Both systems consider the following 
parameters: lymphocytosis, lymphadenopathy, hepato or splenomegaly, hemoglobin 
and platelets. It is usually accepted that patients with Binet stage C and Rai stages III 
and IV should be treated at the onset. The median survival of these patients is 3 to 4 
years. Earlier stage patients with low tumor burden usually have a delay of therapy. 
Some of these are classified as patients with “smoldering CLL” who have the same 
survival as matched controls (Montserrat et al., 1988; Anonymous 1990).
Important prognostic factors for survival are age, atypical lymphocyte morphology, 
cytogenetic abnormalities and doubling time of the lymphoeyets (Zwiebel and 
Cheson, 1998). In addition patients with a diffuse BM infiltration have a worse 
prognosis (Rozman et al., 1984). Soluble CD23 and P2 mieroglobulin are also 
important factors for prognosis (Sarfati et al., 1996) and patients with leukemia eells 
with high telomerase activity have a shorter median survival than those with low 
activity.
1.7.6 Therapy for B-CLL
Chemotherapy. Chlorambucil has been used for decades to treat patients with 
advanced stage disease although it does not appear to improve survival (Dighiero et 
al., 1998). Leukemic cells of treated patients generally develop resistance to further 
therapy. In vitro studies demostrated that this resistance is due to increased protein
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substrate phophorylation and increased Ku-DNA binding activity (Muller et al., 
1998).
Fludarabine has a response rate of 78% and a median survival of 63 months when 
given to patients with aggresive disease (Keating et ah, 1998). Treatment can result 
in immune suppression, causing a decrease in blood CD4+ and CD8+ T cell levels 
and an increased incidence of infections (Schilling and Vadhan-Raj, 1990). 
Autologous stem cell transplantation carries the risk of contamination with CLL cells 
(Gahn et ah, 1997; Gribben et ah, 1994). A few studies have shown complete clinical 
response (Dreger et ah, 1998; Pavletie et ah, 1998; Sutton et ah, 1998). Allogenic 
stem cell transplantation is limited to younger patients who take advantage from 
graft-versus-leukemia response.
Biologic therapy. Rituximab is a humanized monoclonal antibody specific for CD20 
which can induce responses in half of the patients with relapsed follicular lymphoma, 
possibly by directing Ab-dependent cytotoxicity against CD20+ lymphoma B eells 
(Reff et ah, 1994; Maloney et ah, 1997; McLaughlin et ah, 1998). However CLL B 
cells express lower levels of CD20 than most lymphomas and several clinical trials in 
B-CLL are ongoing. CAMPATH-IH is a humanized mAh specific for human CD52, 
a molecule present on CLL B eells and most lymphocytes, including T cells. One 
study reported clinical responses in half of the treated patients even if associated with 
increased incidence of infections (Osterborg et ah, 1997).
Gene therapy. A tumor vaccine with CLL B eells infected with an adenoviral vector 
expressing CD 154 (CD40L) has been planned. It should induce CLL B eells to 
become highly effective APC and induce autologous T eells to generate CTL specific 
for non-infeeted leukemia eells.
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1.8 Aim of thesis
The study of the immunoglobulin heavy ehain (IgH) locus located on chromosome 
14q32 in hematologic tumors has allowed the identification of new important genes 
and established the maturation of preeursor-eells. To this end two regions of the IgH 
locus have been investigated: the V(D)J segments, encoding for variable regions (V) 
of the produced antibody and the switch regions, indispensable for isotype or class 
switching from IgM/D to IgG, IgE, IgA.
The aim of the present thesis is the investigation of IgH switch regions and variable 
regions in two B-cell tumors displaying mainly IgM isotype, gastric mueosa- 
assoeiated lymphoid tissue (MALT) lymphoma and B-cell chronic lymphocytic 
leukemia (B-CLL).
Discovery of new genes has led to the definition of their role in normal eells and to 
their use for diagnosis and, in some eases, for therapy. Numerous hematologic 
tumors are nowadays quite easily diagnosed through identification of specific 
alterations of the IgH locus, such as chromosome transloeations generating fusion 
proteins with new or defective roles. For this reason identification of alterations in 
the IgH locus is fundamental to the definition of pathogenetic events and eventually 
of possible diagnosis systems and new therapeutic options. Chromosome 
transloeations may involve the V(D)J or the switch regions since V(D)J 
recombination and isotype switching are two events occurring in all B eells at 
different points in the development. For example, transloeations of c-mye, bel-1 and 
bel-2 into the Jh region in endemic Burkitt’s lymphoma, mantle zone lymphoma and 
indolent lymphoma respectively, occur during V(D)J recombination. Transloeations
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of c-myc, bcl-3 and bcl-6 into switch regions in sporadic Burkitt’s lymphoma, CLL 
and diffuse lymphoma occur during isotype switch recombination. Chromosome 
transloeations are not the only alteration that may occur in the IgH locus during the 
B-eell development. There might be deletions, insertions, inversions which might 
have a strong impact on the cell's development and behaviour.
To define the maturation of precursor-cells the region of great interest is the V(D)J 
region. This region is first amplified and sequenced and then compared to the 
deposited germline V regions to identify somatic hypermutations. These 
hypermutations contribute to affinity maturation of the antibody and may be of two 
types, common mutations or non-eommon mutations. In the first case all clones of a 
given V gene show the same mutation, in the second case each clone shows its own 
specific mutation generating intraelonal diversity. The presence of intraelonal 
diversity is a hallmark of germinal center B cells, the presence of common mutation 
of post germinal center B eells.
Because of all the important information one can obtain studying the IgH locus 
(identification of new genes, of the maturation stage of preseursor-eells and possibly 
of pathogenetic events) this thesis studied the IgH locus in gastric MALT 
lymphomas and B-CLL. Some aspects of the IgH locus were already known for these 
tumors before starting.
MALT lymphoma cells derive from marginal-zone B eells and show V regions with 
intraelonal diversity. Nobody ever investigated the status of switch regions before 
this thesis. In gastric MALT lymphoma we looked for the presence and nature of 
possible rearrangements of the switch regions. To determine whether gastric low-
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grade MALT lymphomas with or without aberrant rearrangements in the switch 
regions differ in B-eell maturation stage, we investigated the Vh gene mutational 
status. Vh genes were sequenced and analyzed for the presence and nature of somatic 
mutations (common and non-common) and for the presence of possible antigen 
selective pressure.
In B-CLL, previous studies of V genes allowed the definition of this tumor as a 
“heterogeneous disease” since it could be divided into two subgroups. One arising 
from a “naïve” B cell and carrying no mutations in the V region, the other one arising 
from a “memory” B cell and carrying mutations in the V genes. It was also 
established that patients with non-mutated variable genes had a distinctly more 
malignant disease and a much shorter survival than those with somatic mutations. As 
far as the switch regions in B-CLL, is concerned some studies had detected the 
presence of anomalous switch rearrangements in a proportion of eases but the 
molecular nature of these rearrangements was never defined, nor their relation with 
clinical course (Hamblin et al., 1999). In this thesis the presence and the molecular 
nature of the switch region rearrangements in 38 cases of B-CLL was investigated. 
Because of the association of V genes mutational status with elinieal course and 
because of the link of isotype switch with somatic mutations, we investigated the 
relation of switch region rearrangements to the elinieal course.
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Schematic overview of hematopoiesis showing the erytroid, myeloid and 
lymphoid pathways
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Mechanism of immunoglobulin K gene rearrangement. A. RSS marks all sites 
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orientation of the V segment with respect to the J and C segments.
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Chapter 2
MATERIALS AND METHODS
2.1 General procedures
All solutions employed for the preparation and manipulation of nucleic acids were 
made up using distilled water and autoclaved before use or filter-sterilized using a 
0,22 pm filter. Unless stated otherwise, all chemical reagents were supplied by 
Sigma (St.Louis, MO) or Merck (Darmstadt, Germany) and all enzymes were 
purchased from New England BioLabs (Hitchin, Hertfordshire, UK) or Boehringer 
(Mannhem, Germany).
2.2 Flow cytometry (FACS)
Flow cytometry was used to detect the expression of cell surface molecules. 5x10  ^
cells were washed twice in ice-cold PBS and then resuspended in PBS-0.03% BSA. 
The cell suspension was incubated at 4°C for 45 min with the specific fluorochrome- 
conjugated monoclonal antibody (at the optimal pre-determined concentration) or 
with fluorochrome-conjugated polyclonal antibody, as specified in Results. As a 
negative control, PBS-0.03% BSA was added in place of the antibody. After washing 
twice with PBS and spinning down (1200 rpm for 5 min), the cells were resuspended 
in PBS and analyzed using a FACScan or a FACScalibur flow cytometer.(Becton
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Dickinson, Mountain View, CA). Unless stated, all mAbs were purchased from 
Pharmingen (San Diego, CA) and diluted as indicated in the supplier's sheet.
2.3 Immunohistochemistry
Immunoperoxidase assays were carried out on paraffin-embedded sections of MALT 
lymphoma gastrectomies. Briefly, 1 to 2 pm consecutive sections of formalin-fixed, 
paraffin-embedded tissue were cut and mounted in poly-L-lysine (Sigma, St.Louis, 
MO) coated-slides, deparaffined in xylene and rehydrated in grade alcohol. 
Endogenous peroxidase activity was blocked by treatment with 0.3% hydrogen 
peroxide in methanol for 30 min. Slides were incubated overnight with different 
biotinylated monoclonal antibodies specific for Ig isotypes (DAKO). Antibody 
reactivity was detected by incubation with streptavidin-conjugated horseradish 
peroxidase (DAKO), and peroxidase activity was detected by amino-ethyl carbazole 
(AEG). Staining without antibody was performed as a negative control.
2.4 Genomic DNA extraction
High-molecular weight DNA extraction was performed on selected MALT 
lymphoma specimens and on B-CLL peripheral blood mononuclear cells (PBMCs) 
following a "salting out" method. Samples were lysed by incubating overnight at 56° 
C with agitation in 3 ml of lysis buffer (O.OIM TrisHCl pH 8.2, 0.4M NaCl, 0.002M 
Na2EDTA), adding fresh 0.5% SDS and 0.5 ml proteinase K solution (1 mg 
proteinase K in 0.5 ml 1% SDS, 0.002M Na2 EDTA). The following day, 1 ml of 6M 
NaCl was added to the samples, shaken for few seconds and centrifuged at 2500 rpm
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for 15 min. The supernatant was then transferred to a new tube and two volumes of 
95% ethanol was added. After nucleic acid precipitation, the pellet was washed three 
times in 70% ethanol and finally resuspended in 50-200 pi of TE solution.
2.5 Nucleic acid precipitation
Nucleic acids were precipitated by adding 2.5 volumes of ethanol and 1/10 v/v 
sodium acetate and chilled at -20°C for 30 min. After incubation samples were 
centrifuged at 13,000 rpm for 15 min (Sepatech Biofuge, Heraeus Instruments) and 
pellets were then washed twice with 70% v/v ethanol and air dried before 
resuspension in distilled water.
2.6 Agarose gel electrophoresis of DNA
Agarose gels were prepared by adding agarose (0.8% to 1.5% w/v) to IX TAE buffer 
(Tris-acetate-EDTA) and boiling in a microwave cooker for 5 min. After cooling to 
below 50°C 1 pi of ethidium bromide stock solution (lOmg/ml) was added and gels 
were poured into a gel former with a well-comb in place. After setting, the gel was 
submerged in a tank containing IX TAE buffer. Loading buffer (5X solution: 5ml 
glycerol, 1ml lOx TAE, 1ml 10% bromophenol blue, 1ml 10% xylene cyanol, 2ml 
water) was added to the DNA solutions which were then loaded into the wells. 
Electrophoresis was performed at constant voltage (25 to 100 Volts) for variable 
periods of time (20 min to overnight). DNA was visualized using a transilluminator 
with short wave ultraviolet light and DNA fragments were sized by reference to a 
DNA marker run at the same time.
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2.7 Enzymatic digests
Eight or 10 pg of genomic DNA was digested with the appropriate restriction 
enzyme (50U/reaction) in a 100 pi digestion mix containing appropriate buffer 
supplied by the manufacturer, BSA (100 pg/ml), spermidine (1 mM) and RNaseA 
(50 pg/ml).
2.8 Probes
A pair of probes for each isotype, including probes for the non-conventional switch 
region upstream of ô (5’cjp and 3’cjô) were synthesized by PCR using specific 
oligonucleotides reported in Table 2.1.
2.9 Southern blotting
Digested genomic DNA was fractionated by gel electrophoresis on a 0.8% agarose 
gel, denatured with 0.5N NaOH/1.5M NaCl, neutralized with IM Tris-HCl/1.5M 
NaCl and transferred overnight to nylon filters with 20X SSC. The following day, 
filters were air-dried and fixed with UV light (UV Stratalinker).
2.10 Labelling of DNA probes with radio isotopes
Double-stranded DNA fragments were labelled using mixed 
hexadeoxyribonucleotide primers of random sequence employing reagents supplied 
in a kit (Boheringer). 25ng of DNA were boiled at 100°C for 10 min and then mixed 
in a buffered solution containing dNTPs and primers in a total volume of 20 pi.
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Labelling was performed at 37°C for 1 hr with 50 pCi of [a-^^P] dCTP using 10 
Units of Klenow subunit of DNA polymerase. The mix was then passed down a G-50 
Sephadex column to remove unincorporated nucleotides. The labelled product was 
then boiled for 5 min before being added to the hybridization solution.
2.11 Hybridization conditions
Filters were hybridized overnight at 42°C with 1x10^ cpm/ml of probe in a 
hybridization buffer containing IM NaCl, 50mM Tris-HCl pH 7.4, 40% formamide, 
10% dextran sulfate, 1% SDS and 100 ug/ml salmon sperm DNA. The following 
day, filters were washed sequentially in solutions containing 2X SSC/0.1%SDS (20° 
C), IX SSC/0.1%SDS (40°C) and O.IX SSC/0.1% SDS (65°C). They were finally 
exposed to autoradiogram films at -80°C or scanned on a Phosphorimager.
2.12 Long-Distance Inverse PCR cloning
Genomic DNA, digested with the appropriate restriction enzyme, was purified using 
the Wizard DNA Clean-up system (Promega) and 400ng was self ligated at 14°C 
overnight in a total volume of 500 pi with 5U of T4 DNA ligase (Promega). The 
ligated DNA was again purified using the Wizard DNA Clean up system and eluted 
in a final volume of 50 pi. 5 pi were used as template for the PCR reaction which 
contained 200pM dNTPs, primers at 0,2 pM, lU  rTth polymerase (Perkin Elmer) 
and l,2mM magnesium acetate in a final volume of 50 pi. The enzyme was added 
after the first cycle (Hot Start procedure). PCR cycles were as follows: 1 cycle 94°C 
3% 30 cycles 94°C U, 60°C 1’, 72°C 6’, 1 cycle 72°C 10’. 5pl of the PCR reaction
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were reamplifîed for 30 cycles using identical conditions with nested primers. After 
PCR amplification, the products were gel purified and cloned using the PCR-Script 
Cloning kit (Stratagene). Clones were sequenced using an ABI Prism automated 
sequencer
2.13 Polymerase Chain Reaction (PCR) of Vh regions
The VhDJh region was amplified from genomic DNA (1 pg) using a consensus 
forward primer, annealing in the framework 1 region 
[FRlc:AGGTGCAGCTG(GC)(AT)G(GC)(AGT)GG], in combination with a joining 
heavy chain consensus primer
[JHc:ACCTGAGGAGACGGTGACC(AG)(GT)(GT)GT]. The PCR mixture 
contained IX Taq buffer, 0.2 mM of each dNTP, 1 mM of MgCl2 , 10% DMSO, 1 U 
of Taq polymerase (GIBCO) and 1 pM of each primer in a final volume of 50 pi. 
PCR amplification consisted of an initial dénaturation step at 94°C for 5 min, 
followed by 34 cycles at 94°C for 1 min, at 62°C for 1 min and 72°C for 2 min, with 
a final extension step at 72°C for 10 min.
Rearranged VhDJh sequences were also amplified using a semi-nested strategy and 
different primer pairs: FR2 [5’
TGG(AG)TCCG(AC)CAG(GC)C(CT)(CT)C(AGCT)GG 3’], annealing in the 
framework 2 region, and LJH [5’ TGAGGAGACGGTGACC 3’], annealing in the 
joining region. The first round of PCR was performed in 50 pi, containing 200 pM of 
each dNTP, 4.5 mM MgCl2 , 0,7 pM primers and IX Taq buffer. Hot-start was 
performed by the addition of 0.25 U of Taq polymerase (GIBCO) after 7 min at 
95°C. PCR consisted of 30 cycles at 93°C for 45 s, 50°C for 45 s and 72°C for 1 min
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followed by a final extension step at 72°C for 5 min. One microliter of the first 
amplification was used for second-round PCR under identical conditions, except the 
VLJH [5’ GTGACCAGGGT(AGCT)CCTTGGCCCCAG 3’] primer was substituted 
for the LJH primer, MgCli concentration was decreased to 2.5 mM and 20 cycles 
were performed.
2.14 PCR to determine clonality
To determine tumor clonality, a semi-nested amplification of the variable region 
from framework 2 (FR2) to the joining segment (JH) in the IgH locus was 
performed. Cases that did not show monoclonality by FR2/JH amplification were 
then PCR amplified from FRl to the JH region. Resulting PCR products from 
FR1/FR2 amplification were analyzed on a 6% or 8% acrylamide gel respectively. 
Single or double PCR bands indicated monoclonality.
2.15 Purification of Vh fragments from gel
Bands corresponding to Vh genes were isolated from a 2% low-melting agarose gel 
using Jetquick Kit (Genomed) and following the manufacturer’s instructions.
2.16 Cloning of Vh PCR products
Purified Vh fragments were cloned using the TOPO TA Cloning Kit (Invitrogen) and 
following manufacturer’s instructions. Both strands of the inserts were sequenced 
from 3 or more randomly selected bacterial colonies using an ABI sequencer to
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obtain the consensus sequence or sequence of the dominant clone (shared by most 
clones).
2.17 Storage of bacteria
Bacteria were collected during the log phase of growth and were resuspended in a 
solution containing growth medium and 1/3 v/v glycerol. Storage was performed in 
cryotubes at -80®C. To resurrect bacteria from a frozen stock they were scraped, 
inoculated in fresh growth medium and grown overnight in a shaking incubator at 
37°C.
2.18 Small scale preparation of plasmid DNA (“miniprep”)
Plasmid DNA was prepared from small cultures of bacteria using a Wizard 
Minipreps System (Promega, Madison,WI), following the protocol supplied by the 
manufacturer. This procedure is based on the alkaline lysis method for rapid 
extraction of plasmid DNA from bacterial cells followed by adsorption of DNA onto 
silica in the presence of high salt (Vogelstein and Gillespie, 1979).
Single colonies were inoculated into 5 ml of L-broth containing ampicillin and 
incubated overnight in a shaking incubator at 37°C. The next day cells were 
harvested and resuspended in 200pl of cell resuspension solution. 200pl of cell lysis 
solution was then added and mixed, followed by 200pl of neutralization solution 
which causes precipitation of denatured proteins, SDS, cellular debris and 
chromosomal DNA, due to high salt concentration. After centrifugation, supernatants 
were mixed with 1 ml of resin and loaded onto a minicolumn. 2 ml of wash solution
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was added to remove salt and the DNA was eluted by applying distilled water to the 
column.
2.19 Automated sequencing of DNA by the chain termination method
Sequencing reactions were performed using an ABI PRISM Dye Terminator Cycle 
Sequencing Reaction Kit (Perkin Elmer), according to the manufacturer’s 
instructions. Enzymatic extension was performed in an asymmetric PCR using a 
single primer, dye-labeled terminators and the AmpliTaq DNA polymerase FS, a 
mutant form which has no 5’-3’ nuclease activity and reduced discrimination for 
dideoxynucleotides. Each reaction contained: template DNA (500 ng), 3,2 pmol 
Primer, 6 pi Terminator Mix containing the polymerase FS, A, G, C, T Dye-labeled, 
terminators dITP, dATP, dCTP, dTTP, MgCl2 , pyrophosphatase and water to 20 pi 
volume. Extension was performed following the cycles: 96° C for 4 min, 25 cycles at 
96° C for 30 sec, 50° C for 20 sec 60° C for 4 min and a final cycle at 60° C for 3 min. 
After precipitation of DNA, samples were loaded onto a polyacrylamide gel and 
analyzed on an ABI PRISM 377 DNA Sequencer which was operated by the 
Sequencing Service of Istituto Nazionale Tumori, Milan.
2.20 Statistical analyses
Statistical analyses were performed using a GraphPad Prism computer program 
(GraphPad Software, Becton Dickinson). To analyze B-CLL cases, the Fisher’s 
Exact Test was used, for MALT lymphoma cases the Student’s t test. Statistical 
significance was considered to be p < 0,05.
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2.21 PCR of Sp regions and sequence analysis
Genomic DNA (100 or 300 ng) was used as template in PCR reactions with several 
oligonucleotides (Figure 2.1). The reaction mixture contained dNTPs at 200 pM, 
primers at 0.2 pM, 1 U rTth polymerase (Perkin Elmer) and Mg acetate at 1.2mM, in 
a final volume of 25 or 50 pi. PCR cycles were: 1 cycle at 94°C for 3 min, 34 cycles 
at 94°C for 1 min, 62°C for 1 min and 70°C for 5 min and a final step at 70°C for 10 
min. The enzyme was added after the first cycle (Hot Start procedure).
PCR-amplified Sp regions were aligned to the germline sequences HSIMMDL- 
HSJHCMU using the BLAST database to identify deletions and/or DNA 
rearrangements.
2.22 PCR from the VhDJh to the Sp region to localize Sp deletions
Genomic DNA (100 ng) of each patient with Sp rearrangements was amplified using 
a “touchdown” strategy. Forward primers annealing to the specific Vh family 
expressed by each case were used in combination with a reverse primer 
complementary to the 3’ Sp region (3MRA or 3MRB). PCR reaction was performed 
in a final volume of 100 ul with 20 pmol of each primer, 200 pM of dNTPs, 1,2 mM 
of Mg acetate and 2U of rTth DNA polymerase (PE Applied Biosystem) with Hot 
Start technique. Amplification consisted of an initial dénaturation step of 1 min at 
94°C followed by 24 cycles at 94°C for 15 sec and 68°C for 10 min with an 
increasing time of 15 sec in the last 10 cycles. The final extension step was 
performed at 72°C for 10 min.
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PRIMER SEQUENCE 5’-3’
5’apF CAGATCTGAAAGTGCTCTACTG 90885-90906 HSIMMDL
5’SpR TCAGCTAAAGCCATCTCATTGCC 92520-92498 HSMMDL
5MFA GGCTCCTAAATTCTTGGTCTCA 92291-92312 HSIMMDL
5MFB GGCAATGAGATGGCTTTAGCTGA 92498-92520 HSIMMDL
3MRB GTGATGGGGAACGCAGTGTAGA 3803-3781 HSJHCMU
3MRA CCGCAGGCAGCCAATAGAGT 3931-3911 HSJHCMU
CmRl ACACGTGTCAGCCCGGTGCC 534-515 HSJHCMUDE
F igure  2.1
A. Localization o f  the switch p (Sp) probes used for Southern blot assay and o f  the 
primers used for PCR amplification o f  IgH Sp regions. B Primer sequences and relative 
position in GenBank database
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Chapter 3
Analysis of the immunoglobulin switch regions in gastric MALT 
lymphomas
Frozen and paraffin-embedded tissue samples obtained from MALT lymphoma 
gastrectomies were retrieved from our Department of Pathology. For each tumor 
sample, a Giemsa-stained paraffin section was histopathologically analyzed and 
classified either as low or high-grade according to the criteria described by Isaacson 
and Norton (Isaacsoon and Norton, 1994). Five low-grade and two high-grade gastric 
MALT lymphomas were analyzed for the isotype and for clonality. The isotype of 
surface immunoglobulins was determined immunohistochemically on paraffin 
sections using monoclonal antibodies specific for human Ig isotypes and clonality 
was determined by PCR.
Five cases were found to be IgM producing and two cases non-producing. All cases 
showed monoclonality by PCR amplification fi-om FRl, FR2 to JH (Table 3.1). 
Specimens of MALT lymphoma chosen to study rearrangements within the IgH 
switch regions had a percentage of lymphoid tumor cells ranging from 40% to 80%.
3.1 Strategy to analyze immunoglobulin switch regions
To study rearrangements within the IgH switch regions, five pairs of probes (one pair 
for each isotype) that hybridize upstream (5') and downstream (3') of each switch
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region (Fig.3.1) were synthesized by PCR. Using these probes and restriction 
enzymes with digestion sites outside the pair of switch probes, it was possible to 
classify by Southern blot each switch region as germline, or having undergone either 
a physiological or aberrant isotype switch recombination. Upstream and downstream 
switch probes detect the same restriction fragment for germline switch regions. 
Physiological switch recombinations between any two switch regions result in the 
generation of a restriction fragment detected by two probes from different switch 
regions. In contrast, aberrant switch recombination generates restriction fragments 
uniquely detected by only one switch probe.
Genomic DNA from the seven cases of gastric MALT lymphoma was digested with 
different restriction enzymes and screened by Southern blotting using the set of 
probes specific for the switch regions.
3.2 Two cases of low-grade MALT lymphoma have aberrant switch p 
rearrangements.
Case n” 1 produced Ig of the M isotype and showed a small rearranged 5’Sp 
fragment (3.0 kb) on a Hindlll digest that did not eohybridize with any 3’Sp 
fragment (Fig. 3.2b). On a Sphl digest, the 5’Sp probe hybridized to an 8.5 kb 
aberrant fragment which was also identified by the 3’Sp probe. One possible 
explanation for the presence of a 3’Sp aberrant fragment on a Sphl but not on a 
Hindlll digest could be that the aberrant Hindlll digest fragment is either too big or 
too small to be seen by Southern blot. This patient sample showed two rearranged 
bands (12.0 kb and 4.8 kb) with the 5’crp probe on a Bglll digest while the 3’cjô 
probe only detected the germline fragment. No rearranged fragment cohybridized
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with any of the fragments identified by downstream probes, which only identified 
germline fragments (data not shown). Considering the hybridization pattern of the 
Hindlll and Sphl blots , it appears that in this case only one IgH allele underwent 
aberrant recombination in the Sp region, since only one rearranged fragment is 
present in eaeh lane. On the contrary, the Bglll hybridization pattern suggests that the 
aberrant switch recombination involved both IgH alleles (or that the breakpoint split 
the probe). It is possible to suppose that a “downstream” recombination starting at 
aô deleted on one allele sequences downstream of aô but maintained a germline 
configuration upstream of crô. In this situation the 5’Sp and the 3’Sp probes would 
be able to deteet only one rearranged allele and the ô probes would detect the 
rearrangements on both alleles. Rearrangements downstream of the Cp-Cô genes 
were recently reported for IgM expressing Follicular Lymphoma (FL) and it was 
suggested they may reflect a tumor-specific deregulation of the class-switch 
machinery (Vaandragen et al., 1998).
Case n 2 was positive for IgM production after staining with monoclonal anti­
isotype antibodies. Genomic DNA from this case was extracted, digested with 3 
restriction enzymes (Hindlll, Sphl and Bglll) and hybridized with the switch probes 
(Fig.3.2a). The 5’Sp probe showed the germline fragment and two rearranged 
fragments of 7.5 kb and 6.4 kb on Hindlll digest and of 4.7 kb and 3.0 kb on Sphl. 
The 3’Sp probe hybridized to the germline fragment only. As far as the Ô region is 
coneemed, the 5’crp probe identified the germline fragment and two rearranged 
fragments of 7.0 kb and 3.8 kb on a Bglll digest while the 3’(tô probe hybridized to 
the germline fragment only. All rearranged fragments were aberrant since they did 
not hybridize with any other switch region probe (data not shown).
3.2.1 Amplification and cloning of the larger aberrant 5’Sp fragment in Case n° 
2
To amplify the 4.7 kb rearranged fragment observed on Sphl digest with the 5’Sp, 
genomie DNA from case n° 2 was digested with Sphl, self-ligated and long distance 
inverse-PCR was performed using four primers (5MFA, 5MRA, 5MFB, 5MRB), 
internal to the 5’Sp region (Table 3.2). A first PCR amplifieation was done using 
primers 5MFA and 5MRA and a second nested amplification using 5MFB and 
5MRB. As expected, two bands were obtained, one of 4.5 kb and the other of 2.8 kb 
which correspond to to the 4.7 kb and 3.0 kb bands identified by Southern blot and 
therefore to the two Sp alleles. The two bands were purified by gel extraetion, cloned 
using the PCR-Script Cloning kit (Stratagene) and fully sequenced. The sequencing 
of the 4.5 kb band revealed a deletion starting from the Sp region at nucleotide 628 
in HSJHCMU (GenBank nucleotide sequence of the IgH Sp region) to just upstream 
of Cp exon 1 (Cp exon 1 is from 145-456, Cp exon 2 is from 547-882, Cp exon 3 is 
from 1128-1445) at nucleotide 124 in HSIGCMUDE (GenBank nucleotide sequence 
of the human IgH Cp and C5 genes) (Fig. 3.3). The sequence continued through Cp 
exon 2 and it was once again interrupted upstream of Cp exon 3 (position 1018 in 
HSIGCMUDE) with y 3 sequences upstream of the two membrane exons starting at 
10541 in D78345 (GenBank nueleotide sequence of the human Ig y heavy chain) and 
ending at the Sphl site at position 10933. Regions upstream of Sp to the Sphl site at 
90430 in HSIMMDL (GenBank DNA sequence of the human immunoglobulin D 
segment locus) are in the germline configuration. If we assume that the IgH region 
downstream of the Sphl site at 10933 in D78345 is in germline configuration, it is 
plausible that the 6,4 kb fragment on the Hindlll blot and the 7.0 kb fragment on the 
Bglll blot eorrespond to the sequenced fragment.
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3.2.2 Identification of the human switch alpha 2 region from the cloning of the
3.0 kb aberrant fragment in Case n" 2
The characterization of the 3.0 kb band hybridized by the 5’Sp probe on a Sphl 
digest in case 2 allowed the identification of the human switch alpha 2 region. The 
complete sequence of the 2.8 kb fragment obtained by long-distanee inverse PCR 
was eompared with the GenBank database using the BLASTN program and it was 
found that the aberrant fragment was generated by a switch recombination between 
Sp and switch alpha (Sa) (Fig. 3.4). Switch alpha regions are located in the IgH 
locus upstream of the two alpha constant genes (Cal and Ca2), analogous to the 
switch regions and constant genes of other isotypes. Ca2 constant region exists in 
two allotypic forms a2m (l) and a2m(2) (Chintalacharuvu et al., 1994).
In the 2.8 kb aberrant fragment, the sequence upstream of Sp, which normally 
contains the IgH enhancer (Ep), is in germline configuration while the Sp region 
recombined with the Sa region and resulted in the formation of a Sp/Sa hybrid 
region. The Sa sequence (GenBank accession number AF239920) from the first 
nucleotide to nucleotide 144 showed 95% identity with the deposited GenBank S al 
sequenee (HUMIGACHSR from 2544 to 2687), while from nucleotide 189 to 692 
the degree of identity with Sal decreased to 91%. From nucleotide 693 to 876 the 
sequence was 99% identical to the constant alpha 2 region (Ca2) allotype 2 
(sequenee S71043). The only difference occurred at nucleotide 853 where an adenine 
was replaced by a guanine resulting in an amino acid exchange (Glu to Ala) at 
position 21 in the constant alpha CHI domain. Since the repetitive alpha region is 
localized in front of the Ca2 and it shows 98% identity (from nucleotide 509 to 
nucleotide 797) with the P a n  t r o g lo d y te s  Ig alpha 2 heavy chain switch region, it
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probably represents a new sequence of the human Sa2 region. Indeed, to our 
knowledge only a short part of the human Sa2 sequence (HUMIGHATC), localized 
upstream of the sequenced region, has been deposited in the GenBank.
3.3 One case of low-grade MALT lymphoma undergoes an aberrant 
recombination resulting in a partial deletion of the Sp region.
In the IgM produeing case n”3 (Fig. 3.5), the 5’Sp and 3’Sp probes cohybridized to 
the germline fragment and to a fragment of 8.0 kb on a Hindlll digest and of 7.6 kb 
on a Sphl digest. 5’<jp and 3’aô probes cohybridized to the germline and to a 15.8 kb 
fragment on a Bglll digest.
To define the nature of the smaller rearranged bands the Sp region was amplified 
from tumoral genomic DNA by PCR using primers 5’MFB and 3’MRB (Table 3.2). 
As expected, a smaller band compared to the germline was amplified (1200bp versus 
3557bp in HSJHCMU), indicating a deletion of 2350bp internal to the Sp region. 
The 1200bp fragment was cloned into a PCR-Script vector and sequenced. Two 
regions, from nucleotide 246 to 521 and from 3300 to 3803 in HSJHCMU, were in 
germline configuration, indicating that the breakpoint oecured somewhere between 
the two sequenced germline regions.
3.4 Two eases of low-grade MALT lymphoma did not show switch 
rearrangements.
Cases n® 4 and n 5^ showed a hybridization pattern identical to that of placental DNA 
(data not shown) with all switch regions in germline configuration.
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3.5 The two cases of high-grade MALT lymphoma had rearrangements in Sp 
and one of them also in downstream switch regions.
Case n 6 was diagnosed as high-grade MALT lymphoma and it was positive for IgM 
production (Table 3.1). On a Sphl digest it showed, a 5’Sp rearranged fragment of
6.0 kb and a 3’Sp rearranged fragment of 6.5 kb in addition to the germline fragment 
(Fig. 3.6a). Furthermore, on a Bglll digest, the 5’ap  and 3’(jô probes respectively 
hybridized to a 4.5 kb and a 5.0 kb rearranged fragment. Downstream switch probes 
showed no rearrangements.
This aberrant switch recombination may represent a chromosomal translocation 
involving the Sp region. The 5’Sp probe would hybridize to the telomeric 14q32 
which moved to an unknown chromosome and the 3’Sp probe would hybridize to the 
der (14q32). This aberant fragment has not been cloned yet.
Case n*^ 7 (Fig. 3.6b) did not produce Igs and showed multiple rearranged switch 
fragments on a Hindlll digest: one 3’Sp fragment of 18.0 kb, one 3’Sa fragment of
9.5 kb and three 5’Sy fragments of 6.8 kb, 6.5 kb and 3.0 kb, only two of which (6.8 
kb, 6.5 kb) cohybridized with 3’Sy fragments.
3.5.1 Amplification and cloning of the aberrant 3’Sp fragment in Case 7
Since the aberrant 3’Sp fragment was very large (18 kb), additional Southern blots 
with numerous restrietion enzymes were performed. In this way, a rearranged 
3’Sp fragment of 5.0 kb was identified on an BcoRI digest, which was a good 
candidate to be cloned. This fragment was amplified by long distance inverse-PCR
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using primers (3MFA, 3MRA, 3MFB, 3MRB) (Table 3.2) in the 3’Sp region. A 4.5 
kb band was obtained which was cloned and sequenced.
The sequence showed a V(3-43)/D/JH(3) rearrangement followed by a deletion of 
the IgH intronic enhancer (Ep) starting from position 90367 in HSIMMDL 
(downstream of JH6) to the Sp region (2291 in HSJHCMU) (Fig. 3.7a). Moreover, 
there was an insertion of a 336bp region from the gene KIAA0307 (5983-6319) into 
the Sp region with subsequent deletion of the Sp sequence from position 2962 to 
3216 in HSJHCMU. Sequenees of the 3 breakpoints are reported in Fig. 3.7b.
To confirm the IgH enhancer deletion, we performed a PCR on tumor and placenta 
genomic DNA with a forward primer in the JH region (JHF) and a reverse primer 
(3MRB) in the Sp region (Table 3.2). This PCR produced a 3.0 kb band in the tumor 
versus a 6.0 kb product in placenta. As far as the three Sy physiological switch 
fragments (6.8 kb, 6.5 kb and 3.0 kb) is concerned, it is likely that these are extra Cy 
polymorphic alleles. The 3.0 kb band that was identified only with the 5’Sy probe but 
not with 3’Sy probe could be an extra polymorphic Cy allele in which Hindlll cuts 
within the 5’Sy probe, thus giving rise to two germline bands.
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Chapter 4
Analysis of variable heavy chain regions in gastric MALT 
lymphoma and correlation with isotype switch events
Variable heavy chain (V h) analysis was performed on six cases of low-grade MALT 
lymphoma of the stomach. Two cases had been previously analyzed by Southern 
blotting for rearrangements in the IgH switch regions whereas four cases were 
retrieved specifically. The two cases previously analyzed (n° 1 and n° 2) are 
numbered 3 and 2 respectively in the following Vh analysis.
The four new cases, positive for IgM and negative for IgD, were first analyzed to 
determine the configuration of IgH switch regions. On different enzymatic digests 
(Hindlll, SphI, Bglll) one case (n° 1) showed evidence of aberrant isotype switch 
recombination in the Sp region and three cases (n° 4, 5, 6) were in germline 
configuration. Representative hybridizations of the four new cases and of cases n°2 
and n° 3 are shown in Fig. 4.1.
4.1 Variable heavy chain (V h) genes amplification and analysis of common 
mutations
Vh genes were amplified in all 6 cases from genomic DNA using different primer 
pairs (see Materials and Methods) that amplify the complete Vh region from
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framework 1 to the joining heavy region Jh (primers FRl and JH) or the region from 
framework 2 to Jh (primers FR2 and JH).
Cases n° 1, 2, 3 and 4 were amplified from framework 1 to Jh and cases n° 5 and 6 
from framework 2 to JH. In all but one case (n°4), a single monoclonal band was 
amplified (data not shown). In case n° 4 two bands were amplified, which were also 
indicative of monoclonality. Reaction products were then cloned and sequenced, and 
multiple clones for each case were screened. The Vh sequence of each clone was 
analyzed using the immunoglobulin Blast database and compared to the germline 
sequence with the highest homology to identify mutations. Based on the number of 
somatic mutations detected in the Vh genes, cases were classified as “unmutated” or 
“mutated”.
Consistent with current convention, ' 'u n m u ta te e T ' genes were defined as those with 
<2% differences from the most similar Vh germline, while ' 'm u ta te d ^ ' genes were 
those with >2% difference from the closest germline. Homology to published 
germline clones was searched at both the nucleotide and protein levels. A c o m m o n  
m u ta t io n  also called s o m a t i c  m u ta t io n  was defined as a nucleotide substitution 
shared among all clones of a given Vh.
Comparison of the Vh sequences with the known germline genes revealed that one 
case (n° 2) belonged to the Vh3 family, three cases (n° 1, 5, 6) to the Vh4 family and 
one case (n° 3) to the Vh5 family; case n°4 showed a biallelic VhDJh rearrangement 
with VhI on one allele and Vh4 on the other allele (Table 4.1). A biallelic VhDJh 
rearrangement (VhI and V h4 ), was reported in other cases of low-grade and high- 
grade MALT lymphomas (Yumoto et al., 1999; Hallas et al., 1998; Hallas et al., 
1 998^
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Frequencies of common mutations were determined on the d o m i n a n t  o r  c o n s e n s u s  
Vh sequence of each case. Somatic mutations were present in all Vh sequences and 
homology with the closest germline ranged from 89.5 to 98.8% (Table 4.1). The 
frequency of common mutations ranged from 1.2% to 10.5% (Table 4.2) and 
interestingly in patients n° 1, 2 and 3 was higher (mean 7.8%) than in patients n° 4, 5 
and 6 (mean 2.4%) (p=0.05).
Each VhDJh nucleotide sequence was then translated in order to check for amino 
acid replacements. Vh regions of all six low-grade MALT lymphomas revealed the 
correct frame with no stop codons. Expected replacement versus silent mutations 
(R/S) for CDRs and FRs were calculated according to the model of Chang and Casali 
(Chang and Casali, 1994). The ratios of replacement to silent (R/S) mutations in the 
complementarity-determining regions (CDRs) were higher than expected in four 
cases (n° 1,2,4,  5) and lower in the other two cases, whereas in FRs the ratios were 
lower than expected in all cases (Table 4.2). These features are characteristic of 
antigen-selected antibodies which are under positive pressure to provide the “best fit” 
for antigen while retaining framework structure to provide the scaffolding for the 
antigen-contacting CDRs (Chang and Casali, 1994). On the other hand, two cases (n° 
3, 6) displayed lower R/S ratios in the CDRs than expected. A possible explanation 
for this feature may be selection by an autoantigen which usually provides negative 
selection pressure in CDRs to maintain autoantigen binding affinity (Bahler et ah, 
1992; Friedmann, 1991; Friedman et ah, 1991). Consistently the CDR3 translated 
sequences in these 2 cases showed homology to autoantibodies.
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4.2 Analysis of Vh region non-common mutations
N o n - c o m m o n  ( in t r a c lo n a l )  m u t a t i o n s  were defined as nucleotide substitutions 
present in some, but not all clones of a given Vh .Only non-common mutations above 
the estimated Taq polymerase error-rate of approximately 0.2% were considered 
Based on this definition non-common mutations were present in two cases (n° 5 and 
n° 6). For each patient, at least three independent clones were analyzed. Table 4.3 
gives the number of analyzed sequences for each patient and the frequency of non­
common mutations, ranging from 0.2 to 3.5%. Fig. 4.2a shows the sequences of four 
independent clones in case n°5 and Fig. 4.2b of three independent clones in case n°6 
with common and non-common mutations.
4.3 Third complementarity-determining region (CDR3) region analysis and 
homology to known antibodies
A stretch of seven consecutive nucleotide matches was considered indicative of a 
specific variable diversity (D) gene usage. In all but one case (n° 1), the D segments 
showed significant homology to one of the known germline D genes (Table 4.1). One 
case showed usage of the D4 family, one case showed usage of both D5 and D4, two 
cases shared usage of the D3 family, while case n° 4 showed D4 on one allele and D6 
on the other allele. Cases 1 to 5 used Jh4 and case n° 6 used Jh5.
For each patient, the consensus CDR3 nucleotide sequence was translated (Fig. 4.3). 
The length of the CDR3 in MALT lymphomas with aberrant isotype switch ranged 
from 9 to 13 amino acids (mean 11) and in cases without aberrant isotype switch 
ranged from 7 to 12 amino acids (mean 8.7). The length of CDR3 in all cases ranged 
from 7 to 13 amino acids, in accord with reports (2 to 20 amino acids) by others in
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gastric low-grade MALT lymphomas (Hallas et ah, 1998; Bertoni et ah, 1997; 
Thiede et ah, 1998; Qin et ah, 1995; Du et ah, 1996). Surprisingly two cases (4 and 
5) showed similar CDR3 sequences. This similarity suggests the presence of a 
common selecting antigen, as previously described in gastric MALT lymphomas by 
(Bertoni et ah, 1997). Although the two cases have similar CDR3 they differ in the 
type of V(D)J rearrangement and in the level of intraclonal diversity. Case 4 shows a 
biallelic V(D)J rearragement, generating VhI on one allele and Vh4 on the other 
allele while case 5 shows a single Vh4 allele. Moreover case 4 shows no non­
common mutations unlike case 5 that shows a high load of intraclonal diversity (0 
and 23 in Table 4.3). Two N segments were added in the three cases with aberrant 
isotype switch while only one N segment was added in the other three cases. 
Comparison of CDR3 amino acid sequences with GenBank databases revealed high 
homology to known antibodies in four cases. Case n° 3 showed 75% identity with an 
autoantibody from a patient with rheumatoid arthritis and case n° 6, 72% identity 
with an autoantibody from a patient with lupus. Cases n° 4 and n° 5 showed identity 
with an antibody isolated from a patient with Kawasaky disease (77% and 83%, 
respectively), while CDR3 from cases n° 1 and n° 2 showed no homology to any 
known antibody.
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Table 4.3
Aberrant isotype switch, non-common mutations, number of analyzed 
sequences and frequency of nOn-common mutations in 6 cases of gastric 
low-grade MALT lymphoma
Case Aberrant
switch
Non-common
mutations
Sequences 
analyzed (n°)
Frequency (%)
1 Yes 0 5 0
2 Yes 0 4 0
3 Yes 2 3 0 . 2
4 b No 0 4 0
5" No 23 4 3
6 " No 18 3 3.5
 ^analysis of the FR2-Jh region 
^ analysis of the Vh4 allele
N o n - c o m m o n  ( in t r a c lo n a l )  m u t a t i o n s  were defined as a nucleotide substitution 
present in some, but not all clones of a given Vh.
I l l
! #
g.i.
Figure 4.1
Southern blot analysis of IgH switch regions in six gastric low-grade MALT 
lymphomas. Genomic DNA, digested with SphI (cases n° 1 and n° 4) or Hindlll 
(cases n° 2, 3, 5, 6), was electrophoresed, blotted and probed sequentially with 
the 5’ switch mu (5’Sp) probe. Aberrant isotype switch recombination fragments 
are indicated by an arrow and germline fragments by a “g. 1.”.
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r i  Y Y C  A . R E D F G E  S G K G L D  Y W G R G  T
TAT TAC TGT GCG AGA GAA GAG TTC GGT GAA TCC GGG AAG GGT TTG GAC TAC TGG GGC CGG GGA ACC
---------------- :---------—► ^ ----------------i--------
VH4-59 n  D n  JH4
1 2  K C V R P C T F G G  I I V R G G F E T T G A
b iih  TGT GTG AGG CCA TGT ACC TTT GGG GGA ATT ATC GTT CGT GGG GGG TTC GAG ACT ACT GGG GCC
C C a  g g--------------------► ^ ---E------------------- E----------- ► w-------------------
VH3-7 n  D 3-16  n  , JH4
Y Y C A R R  A S G F  D P F D Y W G Q G
TAT TAC TGT GGG CGG CGA GCT AGT GGC TTC GAC CCC TTT GAC TAC TGG GGC CAA GGA 
---------------------------------- a ------ .4 —  ^  <  — ► M -----------------------------T"
VH5-51 n  D 5-12  n  D4^17 JH4
1 4  Y Y C A R G M S G N  F D Y W G Q G T P V
TAT TAC TGT GCG AGA GGA ATG AGT GGG AAC TTT GAC TAC TGG GGC CAG GGA ACC CCG GTC '
a
 ^  ^  ^  ^  :-----------------------------------------------------------------
« n
VH4-59 D 4-17  JH4
' -
f 5 Y Y C A R E M  S G N  F D Y  W G Q G T L V
TAT TAC TGT GCG AGA GAA ATG AGT GGG AAC TTT GAC TAC TGG GGC CAA GGA ACC CTG GTC
VH4-59 n  D 4-17 JH4
Y Y C A R ' G I  T M V R G V K N C F E P W G Q
TAT TAC TGT GCG AGA GGG ATT ACT ATG, GTT CGG GGA GTC AAG AAC TGC TTT GAA CCC TGG GGC CAA
a--------------------=------- — M----------------------------------- ► -4-------------------
VH4-59 D 3-10 n
Figure 4.3
CDR3 consensus sequences of gastric low-grade MALT lymphomas. Vh PCR products 
were cloned and multiple clones sequenced. The deduced amino acid sequence of the 
consensus clone and the VhDJh boudaries are shown. Nucleotide substitutions were 
identified by comparison of the consensus sequence with the published germline family 
sequence.
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Chapter 5
Analysis of the immunoglobulin switch regions and of the variable 
heavy chain genes in B-cell Chronic Lymphocytic Leukemia
5.1 B-cell Chronic Lymphocytic Leukemia (B-CLL) patients and phenotypic 
characterization
Forty patients with clinical features of B-CLL were randomly chosen among a series 
of 145 cases. The mean age of patients at diagnosis was 61.5 years (range, 49 to 83). 
Peripheral blood of these patients revealed expansion of cells with the typical 
phenotype of B-CLL. CD5VCD19^ neoplastic cells represented from 60 to 98% of 
peripheral mononuclear cells and were CD23^ and CD22”, with low or absent CD79b 
expression. Surface immunoglobulin expression was evaluated with FITC-labelled 
F(ab')2 rabbit polyclonal antibodies against human IgM, IgD, IgG, Igk and Ig l 
chains (DAKO).
5.2 Southern blot and PCR analysis of Sp regions in B-CLL cases.
Forty B-CLL patients were initially screened for immunoglobulin isotype; 28 had 
IgM^ B leukemic cells, 8 had IgMVlgD^, two IgG^, one IgD^ and one had non­
producing cells (Table 5.1). DNA was extracted from peripheral blood lymphocytes 
of the 38 patients with “unswitched” isotype, i.e., no evidence of productive isotype
116
switch, and analyzed by Southern blotting using the two probes localized upstream 
(5’Sp) and downstream (3’Sp) of the Sp region (Fig. 2.1 A).
On SphI digestion, DNA from 25 of the 38 patients showed a Sp region in germline 
configuration, while the remaining 13 patients showed additional rearranged bands 
(Fig. 5.1). Hybridization with the 5’Sp probe, revealed seven cases (cases n°
1.2.5.7.27.36.40) with one rearranged band and six cases (cases n° 3,4,18,20,31,35) 
with two rearranged bands. With the 3’Sp probe, ten cases (cases n°
1.2.3.4.5.7.18.20.27.40) presented one rearranged band and three cases presented two 
rearranged bands (cases n° 31,35,36). Interestingly, in all but two of these cases 
(35,36), the rearranged fragments identified by the 5’ and 3’Sp probes cohybridized 
and were about 0.5-4 kb smaller than the germline fragment. The rearranged bands 
all had different sizes (Table 5.2), excluding the possibility that they were 
polymorphic alleles. The cohybridization of the two Sp probes suggested an internal 
deletion in the Sp region (Mukherjee et al., 1993; Zhang et al., 1995).
Indeed PCR using primers 5MFA/3MRA or additional primer pairs located upstream 
and downstream to 5MFA/3MRA indicated the presence of deletions in the Sp 
regions. In all 13 cases with Sp rearrangements, a band of reduced size compared to 
the germline was amplified (Fig. 5.2). Cases in Figure 5.2A were amplified with 
primers 5MFA/3MRA, which amplify a fragment of 3.9 kb when the Sp region is in 
germline configuration, whereas cases in Figure 5.2B were amplified with primers 
5’cjpF/3MRB, which amplify a 5.1 kb fragment when the Sp region is in germline 
configuration. In three cases (cases n° 20,35,40), PCR amplification produced very 
faint bands which are not shown. In all cases, the reduction in size of the PCR- 
amplified products corresponded to the reduction observed for the rearranged bands
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on the Southern blot (Table 5.2).
Specifically, genomic DNA of p a t i e n t s  1 , 2 , 5. 7, 27. a n d  4 0  presented the same 
hybridization pattern with the 5’ and 3’ Sp probes on a SphI digest, and showed the 
germline bands (9 kb) and additional smaller rearranged bands (Fig. 5.1). PCR 
amplification with primers 5MFA/3MRA produced bands of reduced size compared 
to the germline (Fig. 5.2A and Table 5.2). Thus, in all these cases, a deletion internal 
to the Sp region occurred in one allele.
P a t ie n t s  1 8  a n d  2 0  showed the germline bands, two rearranged bands with the 5’Sp 
probe and one rearranged band with the 3’Sp probe (Fig. 5.1). PCR amplification of 
the Sp region produced bands corresponding to the allele recognized by both 5’ and 
3’Sp probes (Fig. 5.2B and Table5.2).
In C a s e  5. Sp deletions on both alleles were observed. Hybridization with the 5’Sp 
probe revealed the germline band and two rearranged bands of 7.5 kb and 7 kb, while 
the 3’Sp probe identified the germline band and only the 7 kb band (Fig. 5.1). PCR 
using primers 5MFA/3MRA amplified a 1.8 kb band (Fig. 5.2A) corresponding to 
the 7 kb allele. On this allele, a 2 kb deletion occurred. PCR using primers 5MFB 
and CmRl, that amplify a 4.1 kb fragment when the Sp region is in germline 
configuration, amplified two bands of 2.3 kb and 2.5 kb, indicating that the 7.5 kb 
allele has a 1.6 kb deletion towards the 3' end and, thus, could not be amplified with 
primer 3MRA.
Even C a s e  3 1  showed Sp deletions on both alleles. Indeed, the two Sp probes
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hybridized to two rearranged fragments of 6.4 kb and 6 kb but failed to hybridize to 
the germline band (Fig. 5.1). PCR with primers 5MFA/3MRA amplified the Sp 
region in only one of the two rearranged alleles, producing one band of 1 kb (Fig. 
5.2A). To amplify the Sp region of both alleles, additional primer pairs were used. 
5MFB and 3MRB produced two bands of 0.8 kb and 0.4 kb, indicating a 2.8 kb 
deletion between 5MFB and 3MRB on the 6.4 kb allele, and a 3.2 kb deletion on the 
6 kb allele.
In C a s e  3 6 , hybridization with the 5’Sp probe revealed a band of larger size than the 
germline, while hybridization with the 3’Sp probe showed the same large band and a 
rearranged band of 5.5 kb (Fig. 5.1). PCR with primers 5MFA/3MRA gave no 
amplified products, while primers 5’cjpF/3MRB amplified a 1.9 kb band (Fig. 5.2B) 
indicating a 3.2 kb deletion towards the 5’ end of one allele.
Similarly, C a s e  3 5  presented bands larger than the germline with the two Sp probes. 
These larger bands might contain a restriction site polymorphism or may be 
generated by insertions (Shapira et al., 1991), or by inversions (Laffan and Luzzatto, 
1992).
Sequencing of the PCR-amplified fragment from C a s e  4  confirmed the presence of 
an internal Sp deletion. This case showed the germline bands and two rearranged 
bands of 8 kb and 5.2 kb with the 5’Sp probe and one rearranged band of 5.2 kb with 
the 3’Sp probe (Fig. 5.1). No reduced size bands were amplified with primers 
5MFA/3MRA, whereas primers 5’apF/3MRB amplified a 1.25 kb band (Fig. 5.2B). 
The sequence of the 1.25 kb band (Fig. 5.3) showed a germline configuration from
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the 5’apF position in HSIMMDL (90885) to position 92021. After the breakpoint 
(ending at position 3671 in HSJHCMU), the sequence continued until position 3803 
in HSJHCMU (3MRB position). Thus, a 3.75 kb deletion occurred on this allele 
between position 92021 in HSIMMDL and position 3671 in HSJHCMU. Additional 
PCRs did not amplify any product from the other allele, which might be involved in 
a translocation, or any other chromosomal rearrangement.
5.3 Localization of Sp deletions in the VhDJh rearranged allele.
To define the allelic localization of Sp deletions, cases bearing these deletions were 
amplified by PCR using a “touchdown” strategy and primers in the Vh region and in 
the 3’ part of the Sp region (see Materials and Methods). Sizes of the VhDJh 
rearranged fragments varied depending on the presence or absence of the Sp 
deletion. Using long-distance PCR conditions, it was possible to amplify the allele 
with the VhDJh and Sp deletion in 8 out of 13 cases (Fig. 5.4). In only one case (n° 
7) the Sp deletion occurred on the unrearranged allele. Case n° 12, that presents a 
VhDJh rearranged allele without Sp rearrangements, was used as control. It was not 
possible to amplify DNA from the remaining 4 cases by long-distance PCR.
5.4 Analysis of variable heavy ehain genes in B-CLL and correlation with 
isotype switch events
Genomic DNA of the 38 B-CLL patients analyzed for rearrangements in the IgH 
switch regions was also analyzed for the presence of somatic mutations in the Vh 
regions. Amplification of the Vh region using consensus primers in the framework 1
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region (FRlc) and in the joining heavy chain region (JHc) resulted in a PCR 
fragment of about 350 bp.
Sixteen cases expressed VhI family genes, 14 cases Vh3, five cases Vh4, two cases 
Vh2, and onr case expressed both VhI and Vh3 (Table 5.3). The number of somatic 
mutations was determined by comparing the V h sequences to the germline genes 
with the highest homology using the Ig Blast database. As previously reported 
u n m u t a t e d ’' genes were defined as those with <2% differences from the most 
similar Vh germline, while ' " m u ta t e d ' genes were those with >2% difference from 
the closest germline. Somatic mutations ranging from 2.3% to 11.6% were observed 
in 16 cases while the leukemic cells of 21 patients had V h genes with >98% 
sequence homology with the nearest germline gene. In the remaining case presenting 
a productive rearrangement of both variable regions, a VhI-2 in germline 
configuration and a V h3 -4 8  in mutated form was observed. A biallelic V hD J h 
rearrangement was reported in other cases of B-cell CLL (Rassenti and Kipps, 1997) 
and it is not an infrequent event, since about 5% of B-CLL cells lack 
immunoglobulin heavy chain allelic exclusion. Of the two productive V h genes, one 
was mutated and the other was not, consisistent with the finding that B-CLL without 
allelic exclusion can express one allele without somatic mutation along with the 
other allele that has undergone somatic mutation (Rassenti and Kipps, 1997). Cases 
with Vh mutations showed overusage of the Vh3 family while cases without Vh 
mutations showed over usage of the VhI family. In 8/17 cases with Vh mutations, 
R/S ratios in the complementary determining regions were higher than expected from 
random distribution while in the framework regions the ratios were lower.
No correlation between the presence of Sp rearranged bands and Vh gene mutations
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was observed, since 4 of 13 cases (32%) with a deletion in the Sp region showed Vh 
mutations, and 13 of 25 of cases (52%) without deletion in the Sp showed Vh 
mutations (p=0,13).
5.5 Clinical observations
The clinical course of 22 patients with a follow-up period of at least five years was 
related to the presence of Sp rearranged bands and Vh mutations. The presence of 
switch rearrangements alone was not indicative of the clinical course. Indeed, out of 
eight cases with switch rearrangements five (cases n° 1,20,27,35,36) underwent 
disease progression (62.5%) whereas out of 14 cases without switch rearrangements 
six (no 13,19,21,24,26,30) underwent progression (42,8%) (p=0,24). On the contrary, 
the presence of Vh mutations was indicative of the clinical course. Out of 11 cases 
with Vh mutations only three cases (cases n° 13,24,35) were in progression (27,2%) 
whereas out of 11 cases without Vh mutations eight cases (cases n° 
1,19,20,21,26,27,30,36) (72%) were in progression (p=0,04).
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Table 5.1. Immunoglobulin isotype and presence of Sp rearrangements in B-CLL
patients
Patients Immunoglobulin isotype Sp rearranged bands
1 p/5 yes
2 g yes
3 F yes
4 g yes
5 F yes
6 p/ô no
7 g yes
8 g no
9 g no
10 F no
11 g no
12 F no
13 g no
14 F no
15 g no
16 g no
17 yl not assayed
18 g yes
19 F no
20 F yes
21 g no
22 g no
23 F no
24 p/5 no
25 p/5 no
26 p/5 no
27 g yes
28 no
29 y not assayed
30 no
31 g yes
32 no
33 F no
34 p/5 no
35 non-producing yes
36 p/5 yes
37 g no
38 5 no
39 g no
40 p/5 yes
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Table 5.2. Southern blot and 
rearrangements.
PCR results for the 13 cases with
Case
Rearranged fragments 
size (kb)^
5’Sp 3’Sp
PCR 
fragments 
size (kb) Prim er pairs
PCR 
deletion 
size (kb)
1 8 8 3 5MFA-3MRA 0.9
2 8.5 8.5 3.5 5MFA-3MRA 0.4
3 7
7.5
7 1.8
2.5
5MFA-3MRA
5MFB-CmRl
2.1
1.6
4 5.2
8
5.2 ’ 1.25 5'apF-3MRB 3.75
5 7.5 7.5 ; 2.5 %5MFA-3MRA 1.4
7 7.2 7.2 2.3 5MFA-3MRA 1.6
18 6
8
6 2.5 5'opF-3MRB■Ç- 2.6
20 8.5
6.5
8.5 • 3.5 5MFA-3MRA 0.4
27 6.4 6.4 '
r  V
1.5 5MFA-3MRA 2.5
31 6.4 6,4 1 and 0.8 5MFA-3MRA 
and 5MFB- 
3MRB
2.8
6 6 0.4 5MFB-3MRB 3.2
35 6.1 6.1 0.9 5MFA-3MRA 2.9
36 5.5 ■ 1.9 5'apF-3MRB 3.2
40 8.5 8.5 3.5 5MFA-3MRA 0.5
'only rearranged fragments smaller than'the germline are indicated
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Table 5.3. Vh somatic mutation analysis and presence of Sp rearrangements in B-
CLL patients
Sp FRs CDRs
p rearranged Germline Homology R/S R/S P R/S R/S P
bands VH % 0 e 0 e
1 yes V H l-2 99.7 0 nd nd 0 nd nd
2 yes VH3-15 96.7 0.5 233 0.019" 3 4.06 0.190
3 yes VH3-30.5 100 0 nd nd 0 nd nd
4 yes VH l-69 100 0 nd nd 0 nd nd
5 yes V H l-2 100 0 nd nd 0 nd nd
6 no V H l-2 100 0 nd nd 0 nd nd
7 yes VH3-72 97.7 4 2.80 0.293 >2 4.06 0.265
8 no V H l-69 99 0 nd nd 2 333 0.078
9 no VH3-7 91.2 3.3 2.85 0.024" 5.5 4.08 0.002"
10 no V H l-69 100 0 nd nd 0 nd nd
11 no VH3-21 97.6 2 2.82 0.096 >4 4.03 0.019"
12 no VH4-59 94.5 0.62 2.64 0.025" 0.5 4.55 0.153
13 no VH2-70 96 2 2.87 0.198 2 4.09 0.292
14 no VH2-70 100 0 nd nd 0 nd nd
15 no VH3-11 100 0 nd nd 0 nd nd
16 no V H l-2 VH3-48 100 95.6 0 1 nd 2.82 nd 0.035" 0 >5 nd 4.04 nd 0.049"
18 yes V H l-2 926 1.5 2^8 0.045" 6 3.94 0.102
19 no VH4-4 100 0 nd nd 0 nd nd
20 yes VH l-69 100 0 nd nd 0 nd nd
21 no VH4-39 100 0 nd nd 0 nd nd
22 no VH3-74 91.9 1.25 2.84 2.34x10-4" 6.5 4.05 5.50x10’^ "
23 no VH3-48 9&6 0.25 232 0.003" 4 4.04 0.066
24 no VH3-7 926 >6 2.84 0.014" 12 4.05 1.40x10'^"
25 no VH l-69 99 0.5 3.01 0.305 0 nd nd
26 no V H l-2 100 0 nd nd 0 nd nd
27 yes VH3-30 98.6 0 nd nd 1 4.01 0.129
28 no V H l-2 99J >2 2.97 0.141 0 nd nd
30 no V H l-69 993 1 3.01 0.487 0 nd nd
31 yes V H l-46 100 0 nd nd 0 nd nd
32 no V H l-69 100 0 nd nd 0 nd nd
33 no V H l-8 97 2 235 0.027" 5 3.90 0.010"
34 no VH3-53 88.4 0.57 2.83 3.61x10'^" 5 4.08 0.032"
35 yes VH4-34 95.2 0.28 2.65 0.001 " 4 4.44 0.138
36 yes VHl-3 926 1 2.99 0.170 >2 3.94 0.128
37 no VH3-48 89.2 1.5 232 0.011 " 11 4.04 0.012"
38 no VH4-34 925 1.5 2.64 0.055 2.5 4.47 0.165
39 no VH3-33 94.3 1.2 2.85 0.037" >6 4.01 0.046"
40 yes VH3-30 9&7 0 nd nd 1 4.01 0.129
P= patients; CDRs = Complementarity-determining regions (CDRl and CDR2); FRs =. Framework regions 
(FRl, FR2 and FR3); R = number o f replacement mutations; S = number of silent mutations; R/S o= observed; 
R/S e (expected) = mutation ratio of the total possible R to total possible S mutation; P = probability; 
statistically significant (P<.05)
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Figure 5.1
Southern blot analysis of Sp regions in B-CLL patients. Genomic DNA of B-CLL 
patients was digested with SphI restriction enzyme, electrophoresed, blotted and probed 
sequentially with 5’Sp and 3’Sp probes. The hybridization pattern of 13 cases with 
rearranged Sp bands and one case (n® 32) in germline configuration is shown. 
PC=placental genomic DNA used as germline control.
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Figure 5.2
PCR amplification of the Sp region in patients with Sp rearranged bands. A.
Anplification of seven B-CLL cases with 5MFA/3MRA primer pair. B. Amplification of 
three cases with 5’opF/3MRB primer pair.
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Figure 5.4 
Amplification of the rearranged VhDJh allele in B-CLL cases.
VhDJh rearranged allele was amplified using a forward primer annealing to the variable 
region in combination with a reverse primer specific for the 3 ’ switch mu region.
Case 12, that did not present rearrangements in the Sp region, was used as control.
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Chapter 6
DISCUSSION
The present thesis examines closely the immunoglobulin heavy chain (IgH) switch 
regions and variable regions in two hematological B-eell tumors, Mucosa-Associated 
Lymphoid Tissue (MALT) lymphoma and B-eell Chronic Lymphocytic Leukemia 
(B-CLL).
6.1 MALT lymphoma IgH switch regions
MALT lymphoma cells are thought to derive from marginal zone B-cells that are 
typically CD5’, CD 10' and IgM^IgD" (Harris et ah, 1994; Wotherspoon, 1998). In 
order to define the differentiation of MALT lymphoma cells, numerous investigators 
sequenced the Ig variable heavy chain (V h ) genes and found frequent somatic 
hypermutations that could be ongoing (Hallas et ah, 1998; Qin et ah, 1997). Somatic 
hypermutations, together with isotype switch recombination, contribute to the 
process of B-cell maturation. Intrigued by the ability of MALT lymphoma cells to 
undergo somatic hypermutation of the variable genes and maintain in the majority of 
cases an “M” isotype, we investigated the ability of seven gastric MALT lymphoma 
to undergo DNA rearrangements within or near IgH switch regions.
Using a specific set of probes for the IgH switch regions we found by Southern blot 
that three out of five low-grade cases and two out of two high-grade cases showed
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rearrangements within IgH switch regions, that appeared aberrant in four of the five 
cases. The cloning of four rearranged fragments from two low-grade and one high- 
grade confirmed the aberrant nature of the rearranged fragments.
In the low-grade case n“ 2 the two aberrant fragments detected by the 5’Sp probe 
were cloned and characterized. The 4.7 kb aberrant fragment was generated by a 
deletion from the switch p region (Sp) to the first constant p exon (Cp 1) and a 
second deletion from the second constant p exon (Cp 2) to the gamma 3 region (y 3) 
(Fig. 3.3). Since the first breakpoint clearly oceuired in the Sp region, it was 
probably generated by an error during the process of isotype switch recombination. 
Indeed, the molecular mechanisms of isotype switch recombination, V(D)J- 
recombination and somatic hypermutation are now becoming clearer and it is known 
that these events involve DNA double strand breaks. On the contrary, the 
mechanisms occurring during other type of recombinations are not yet known; for 
example, what happens to the partner chromosome during translocations involving 
the IgH locus (Kuppers and Dalla-Favera, 2001). Therefore the second breakpoint, 
which does not involve any switch region, might have been generated by an aberrant 
recombination other than a switch recombination. This aberrant recombination would 
have been facilitated by increased accessibility due to the first attempt to undergo a 
DNA switch to y3 isotype.
The cloning of the 3.0 kb aberrant fragment detected by the 5’Sp probe allowed the 
identification of the human switch alpha two (Sa2) region, which had never been 
sequenced before. To our knowledge only a short part of the human Sa2 sequence, 
localized upstream of the region identified in this project, was deposited in the 
GenBank (HUMIGHATC). It is not excluded that the Sa2 sequence obtained from 
this low-grade MALT lymphoma might contain somatic mutations due to the tumor
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origin of the starting DNA. Moreover, although this ease is IgM-producing, 
rearrangements involving the Sa regions are not surprising for a B-eell lymphoma 
associated with mueosal tissue which, is normally enriched with IgA antibodies. The 
2.8 kb allele is possibly the non functional allele, while the 4.5 kb allele is the 
productive one. Indeed during the attempt to undergo an isotype switch 
recombination two DNA deletions occurred on this allele which, do not involve the 
region for the transcription of the V(D)J-Cp message. Therefore, the 4.5 kb allele 
would still be able to produce a functional IgM antibody.
The cloning and sequencing of the aberrant fragments in case n® 3 (low-grade) 
revealed that chromosome 14 undergoes a DNA recombination resulting in a partial 
deletion of the Sp region. It has been suggested that a similar internal deletion or 
rearrangement of the Sp region can occur in IgM-producing B cells to stabilize the 
isotype of the expressed immunoglobulin (Zhang et al., 1995).
In the 3’Sp aberrant fragment of case n” 7 (high-grade), a double recombination 
event occurred on chromosome 14q32: a deletion of the IgH intronic enhancer (Ep) 
determined by a cut from Jh6 to Sp and a 336bp insertion into the Sp region of a 
gene (KIAA0307) normally located at 15q24 (Fig. 3.7a). As far as the insertion into 
the Sp region is concerned it is possible to hypothesize that, it occurred during an 
attempt to undergo an isotype switch recombination. A dysregulation of the inserted 
KIAA0307 gene by the IgH 3’ LCR is not likey since the insertion involves an 
intronic sequence of the gene. Much more interesting for the pathogenesis of the 
tumor is the deletion from chromosome 14 of the IgH intronic enhancer (Ep) which, 
together with E a l and Ea2 located downstream of the alpha genes, has an essential
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regulatory function for the expression of immunoglobulins. During chromosome 
translocations involving the IgH locus, the 3’ enhancers may remain on the 
derivative chromosome 14 or may be dissociated but in both cases they have the 
potential to dysregulate juxtaposed oncogenes. It is possible to assume that in case 7 
the IgH Ep moved somewhere else in the genome, where, as previously reported for 
mouse plasmacytoma (Corcoran et al., 1985), it dysregulated an oncogene. 
Alternatively the Ep might have been simply deleted from the cell. Future 
experiments will be planned to localize precisely the deleted intronic Ep in this case.
The cloning of the four aberrant fragments and the discovery that they derive from 
alterations of the switch regions implied that switch aberrant fragments were 
generated by mistakes of the cell during an attempt to undergo a physiological 
isotype switch recombination. Many B-eell malignancies produce errors during the 
developmentally regulated processes of V(D)J-recombination, isotype switch 
recombination and somatic hypermutation (Kirseh, 1993; Korsmeyer, 1992). By 
analyzing IgH locus rearrangements within the V(D)J or switch regions and by 
considering the status of V(D)J hypermutation, it is possible to estimate the stage of 
B-cell development at which malignant transformation occurred (Matolcsy et al., 
1997). For example. Mantle Cell Lymphoma, a tumor of virgin slgM^ B-cells, does 
not show V(D)J hypermutation or switch recombination and is characterized by a 
recurrent t(l I;14)(ql3;q32) occurring within Jh regions adjacent to heptamer- 
nonamer recognition sequences (Meeker et al., 1989; de Boer et al., 1993). Follicular 
Lymphoma, deriving from surface IgM^ B-cells, shows ongoing V(D)J 
hypermutations and is characterized by a typical t(14;18)(q32;q21) occurring within 
Jh exons (Rack et al., 1998; Wu et al., 1994; Tsujimoto et al., 1985). In Burkitt’s
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Lymphoma, there is evidence of ongoing V(D)J somatic mutations. Furthermore, 
these tumors are characterized by a t(8;14)(q24;q32) with breakpoints within Jh 
exons (endemic form) or within Sp regions (sporadic form) (Neri et al., 1988; 
Chapman et al., 1996; Magrath, 1990). Finally, Multiple Myeloma is a tumor of 
mature plasma cells which clearly undergo V(D)J somatic mutations and isotype 
switch recombination. Typical transclocations are promiscuous and may involve all 
switch regions (Bergsagel et al., 1996). MALT lymphoma cells show V(D)J 
hypermutations that can be ongoing (Hallas et al., 1998; Qin et al., 1997) and, as 
demonstrated in this work, can undergo IgH switch recombination. Therefore, it is 
possible to suggest that IgM^ MALT lymphoma cells which do not show evidence of 
a switch recombination possibly originate from a less differentiated B-cell.
On the contrary it is not possible to determine if these aberrant recombinations 
occurred before or after the onset of malignancy. In the first ease they would be 
involved in the development of the tumor, in the second case in the progression. In 
Multiple Myeloma it was possible to estimate the timing of occurrence of 
translocations, dividing them into primary translocations and secondary 
translocations (Bergsagel and kuehl, 2001) Through future studies of IgH 
rearrangements it will be possible to understand if some rearrangements are more 
frequent in low-grade than in high-grade MALT lymphomas.
Experiments on IgH switch regions demonstrate that the frequency of IgH switch 
rearrangements, other than normal class switching, has been grossly underestimated 
by other studies. The Southern blotting assay allowed us to estimate that aberrant 
switch recombination is a frequent event in MALT lymphomas.
Despite the very limited number of patients, the presence of aberrant switch 
recombination in low-grade lymphomas appeared to be associated with clinical
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outcome. Cases without evidence of aberrant switch recombination had a shorter 
median disease free time after gastrectomy (6 months) compared to those with 
illegitimate switch recombinations (up to 56 months).
The cloning of a t(l;14)(p22;q32) transloeation breakpoint from one case of MALT 
lymphoma allowed the identification of a new gene (Bel 10), which is also altered in 
other tumor types (Willis et al., 1999). Bel 10 is a novel apoptotic signalling gene that 
encodes an amino-terminal easpase recruitment domain and is overexpressed and 
truncated in MALT tumors carrying the t(l;14)(p22;q32) (Zhang et al., 1999). 
Mutant BcllO overexpression would provide anti-apoptotie and proliferative signals 
and confer a survival advantage to MALT B-cells.
During work described in this thesis, BcllO was never detected probably because the 
t(l;14) is a rare event in MALT lymphoma. However, the precedent set by the 
investigation of the t(l;14) transloeation, suggested that the identification of aberrant 
switch recombination fragments in MALT lymphoma could give insights into the 
potential pathogenic role of new dysregulated genes.
6.2 MALT lymphoma variable genes
As shown by previous studies on switch regions, aberrant isotype switch events 
occur in an important proportion of gastric MALT lymphomas. Since isotype switch 
recombination and somatic hypermutation of immunoglobulin variable genes are 
markers of B cell maturation, gastric MALT lymphomas with or without aberrant 
rearrangements in the switch regions were examined for differences in maturation. 
First, as determined by Southern blot analysis of six gastric MALT lymphoma cases, 
aberrant isotype switch events which were found in three cases (Fig. 4.1). Then the
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six cases were analyzed for the presence and type (common or non-common) of 
somatic hypermutations. Although it was supposed that somatie hypermutations may 
occur outside germinal centers it is well established that they oeeur usually in 
germinal centers (Davila et al., 2001). Moreover the detection of intraclonal 
diversification allows discrimination between germinal centers B cells, which show 
non-common mutations, and post germinal center B cells which do not (Kuppers et 
al., 1993).
Somatic common mutations were present in the immunoglobulin variable heavy 
chain genes of all six eases and homology with the closest germline ranged from 89.5 
to 98.8%. A biased usage of the Vh 4 family and over-usage of D4-17 and of Jh4 
segments was observed. An over-usage of a specific Vh family (Vnl-69), has been 
reported only in salivary gland MALT lymphomas (Miklos et al., 2000) while a 
predominant usage of Jh4 segment in gastric MALT lymphomas has been previously 
observed (Bertoni et al., 1997; Qin et al., 1995; Qin et al., 1997; Thiede et al., 1998). 
The clonal Vh genes of all six low-grade MALT lymphomas were potentially 
functional because no stop codons were present and the CDR3 sequences were all in­
frame. Further analysis was performed to assess whether the mutation rate was due to 
antigen-driven selection. In the absence of negative or positive selection on a gene 
product, somatic hypermutations yielding amino acid replacement (R mutations) and 
not yielding amino acid replacement (S mutations) are randomly distributed 
throughout the coding sequence. A lower than expected frequency of R mutations 
indicates the pressure to mantain the protein sequence due to essential functions. By 
contrast if the number of R mutations exceeds that expected by chance alone, a 
positive selection process can be inferred. In four cases, the R/S ratios in the CDRs 
and FRs were charaeteristic of positively-selected or antigen-selected antibodies
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which are under positive pressure to provide the “best fit” for antigen (Chang and 
Casali, 1994). On the other hand, two eases displayed R/S ratios that suggest 
selection by an autoantigen (Bahler et al., 1992; Friedmann, 1991; Friedman et al., 
1991), and the CDR3 translated sequences in these two eases showed homology to 
autoantibodies. Surprisingly, two eases showed similar CDR3 sequences suggesting 
the presence of a common selecting antigen, as previously described in gastric 
MALT lymphomas by Bertoni et al. (Bertoni et al., 1997). The high R/S ratios in 
CDRs and low R/S ratios in FRs or the homology with autoantibodies coupled with 
the presence of intraelonal diversifieation, eonfirm the positive selective pressure of 
an antigen that plays a fundamental role in the pathogenesis of this disease, 
especially during the low-grade stage (Greiner et al., 1994; Hussell et al., 1993). 
Isotype switeh and Vh genes analysis in the six cases revealed several charaeteristics 
that suggest the existenee of two distinct subsets of gastric low-grade MALT 
lymphoma.
First, high levels of intraclonal diversification were found in two of three cases 
without isotype switch events.
Secondly, lower levels of common mutations (2.4% on average) were found in cases 
without aberrant isotype switch events than in cases with sueh switch events (7.8% 
on average). Thus, one subset of gastric low-grade MALT lymphomas is 
eharaeterized by Vh intraclonal diversification, few eommon mutations, and no 
aberrant isotype switch, whereas the other subset is characterized by the absence of 
Vh intraclonal diversification, many common mutations, and aberrant isotype switch. 
It is possible that the first subset originated from a germinal center environment and 
the second subset from a post-germinal center. Alternatively the initial transforming 
event might have occurred within the germinal center and additional maturation or
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transforming events blocked the mutational mechanism. Further studies are needed to 
determine whether these two subsets have prognostic relevance and enable better 
evaluation of therapeutic modalities.
6.3 B-CLL analysis of IgH switch regions
B-cell Chronie Lymphocytic Leukemia (B-CLL) cells express mostly unswitched 
immunoglobulins (IgM or IgM/IgD), although non-productive rearrangements in the 
heavy chain switch mu (Sp) have been detected in a proportion of eases (Crossen and 
Morrison, 1998; Laffan and Luzzatto, 1992; Hakim et al., 1993). Thirtyeight cases of 
B-CLL were investigated for the presence of non-productive rearrangements in the 
Sp region and, for the first time, the molecular nature of all these rearrangements was 
defined. Southern blot analysis revealed Sp region rearrangements in 13 cases (34%) 
and polymerase chain reactions (PCRs) indicated that these rearrangements consisted 
of internal deletions in the Sp region. Long-distance PCRs localized the Sp deletions 
in the VH(D)JH-rearranged allele in eight cases and in the unrearranged allele in only 
one case. Therefore most of these Sp region rearrangements, previously observed in 
B-CLL by other investigators, are genomie deletions of the Sp region oeeurring in 
most cases in the VH(D)JH-rearranged allele. These deletions are of variable length, 
ranging from 0.5 kb to about 4 kb and may involve the region upstream or 
downstream the Sp region but never the constant p exons. The random distribution 
of these deletions might be related to the absence of a consensus-cutting site inside 
the Sp region (Dunnick et al., 1993; Kinoshita et al., 1998). In two eases (cases n° 3 
and 31), the Sp deletion oeeurred on both alleles which is not surprising since there 
is no evidence suggesting that the switeh mechanism can distinguish between the
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productive and non-productive allele in a B cell (Sakai et al., 1999). However, Sp 
deletions are in most cases found within the VH(D)JH-rearranged allele, thus strongly 
supporting the hypothesis that B-CLL eells have undergone this partial deletion of 
the Sp region in order to stabilize the isotype of the expressed immunogloblin 
(Mukherjee et al., 1993; Zhang et al., 1995). Indeed, although it was demonstrated 
that the Ig heavy chain intronic enhancer is necessary and sufficient to promote class 
switch recombination (Sakai et al., 1999), a deletion of the Sp tandem repeats in the 
mouse immunoglobulin heavy chain locus reduces the efficiency of class switching. 
The hypothesis of isotype stabilization is not incompatible with the presence of 
isotype-switched transcripts, previously deseribed in IgM^ B-CLL eells (Malisan et 
al., 1996). As mentioned above, even a cell with Sp deletion can undergo isotype 
switch recombination, although with lower efficiency.
Sp internal deletions might also represent “failed switehing attempts”, as suggested 
by Q. Pan e t  a l ,  who frequently deteeted internal deletions in the Sp, Sy4 and Sy3 
regions. (Pan and Hammarstrom, 1999). Possibly, “failed switching attempts” may 
themselves contribute to isotype stabilization. This mechanism can explain why only 
a small proportion of B-CLL cells undergo isotype switch and might be highly 
relevant to the proeess of isotype switehing in this leukemia. It is unknown if Sp 
deletions occur in a B cell before or after malignant transformation; however, the 
demonstration that these rearrangements are Sp internal deletions and not 
chromosome translocations rules out their involvment in the onset of malignaney.
6.4 B-CLL variable genes
For a long time, it was assumed that the proeesses of isotype switeh recombination
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and somatic hypermutations of the variable genes were unrelated phenomena (van Es 
et al., 1992; Wysoeki et al., 1992; Gilmore et al., 1987) and indeed it is possible to 
have IgM^ cells with Vh mutations (Sehettino et al., 1998) and IgG^/A^ eells without 
Vh mutations (Matolcsy et al., 1997). It appears, however, that these two 
developmentally regulated processes occur in temporal correlation (Wahl et al., 
1999) and new links between them are becoming clearer day by day (Kinoshita and 
Honjo, 2001).
Intrigued by this relation, we investigated if Sp deletions are related to Vh somatie 
mutations in B-CLL. Sequencing of the Vh regions of all 38 eases indicated the 
presence of somatie hypermutations in the Vh genes of 17 cases (44,7%). In one 
case, two productive Vh genes were expressed, whieh is not infrequent, since about 
5% of B-CLL cells lack immunoglobulin heavy chain allelic exclusion (Rassenti and 
Kipps, 1997). Of the two productive Vh genes, one was mutated and the other was 
not. Of interest, cases with Vh mutations showed overusage of the Vh3 family while 
cases without Vh mutations showed overusage of the VhI family. Overusage of the 
VhI family by B-CLL leukemic cells has been extensively reported (Sehroeder and 
Dighiero, 1994; Maloum et al., 2000; Fais et al., 1998; Kipps et al., 1989) while only 
recently overusage of the V h3 family (in particular V h3 -2 1 )  has been associated with 
mutated Vh genes (Tobin et al., 2002). Biased VH gene usage might derive from 
chronic antigenic stimulation and play a role in the development of malignancy. In 
8/17 cases with Vh mutations, it was indeed possible to postulate the effect of 
selection by an antigen sinee R/S ratios in the CDRs were higher than expected from 
random distribution and in FRs were lower (Maloum et al., 2000; Chang and Casali, 
1994; Fais et al., 1998; Kipps et al., 1989; Sehroeder and Dighiero, 1994). It is 
tempting to speculate on a possible role for antigens in the development of some B-
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CLL; these antigens could bind specific epitopes eneoded by the overused Vh gene 
and stimulate proliferation of the malignant elone. Future studies will be necessary to 
clarify the possible role of specific antigens in the pathogenesis of B-CLL.
No correlation between the presenee of Sp deletions and the presenee of Vh gene 
mutations was observed, since 32% of cases with a deletion in the Sp region showed 
Vh mutations, and 52% of cases without deletion in the Sp showed Vh mutations. 
Therefore, Sp internal deletions might oeeur independently of Vh mutations and 
eonsidering the Vh status as a marker of B-eell maturation, Sp deletions might oeeur 
independently of the B cell maturation. This is quite different from other genetic 
abnormalities in B-CLL, such 13ql4 deletions whieh occur preferentially in “post- 
germinal center” memory B-cells and trisomy 12 in “pre-germinal center” naïve B- 
cells. An additional hypothesis is that all eases of B-CLL do not derive from B eells 
with different maturation but from a eell with the unique features of a “memory B 
cell”. Indeed recent gene expression profile analyses showed that B-CLL display a 
common and characteristic gene expression profile that is largely independent of 
their IgV genotype and that resembles features of memory B eells (Klein et al., 2001; 
Rosenwald et al., 2001).
Moreover, while a correlation of Vh mutations with disease progression was 
detected, confirming recent data on the possible use of Vh status as a prognostic 
factor (Hamblin et al., 1999), Sp rearrangements alone did not appear to be 
indicative of clinical course. Together these data indicate that in B-CLL Sp internal 
deletions occur independently of Vh somatic mutations and have apparently no 
consequence for disease outcome.
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